fluconazole has been researched along with Fungemia in 368 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Fungemia: The presence of fungi circulating in the blood. Opportunistic fungal sepsis is seen most often in immunosuppressed patients with severe neutropenia or in postoperative patients with intravenous catheters and usually follows prolonged antibiotic therapy.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether Candida glabrata colonization and invasive candidiasis (IC) increased among critically ill surgical patients 3 years after the introduction of fluconazole prophylaxis to a surgical intensive care unit (SICU)." | 9.14 | The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. ( Colantuoni, EA; Fothergill, AW; Hendrix, CW; Lipsett, PA; Magill, SS; Merz, WG; Shields, CE; Swoboda, SM, 2009) |
| " We compared anidulafungin with fluconazole in a randomized, double-blind, noninferiority trial of treatment for invasive candidiasis." | 9.12 | Anidulafungin versus fluconazole for invasive candidiasis. ( Betts, R; Chapman, SW; Goldstein, BP; Kett, DH; Krause, DS; Kumar, D; Pappas, PG; Reboli, AC; Rotstein, C; Schranz, J; Walsh, TJ; Wible, M, 2007) |
| "To compare the efficacy and toxicity of fluconazole and amphotericin B in the treatment of hematogenous candidiasis in cancer patients." | 9.08 | Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. ( Abi-Said, D; Anaissie, EJ; Bodey, GP; Gardner, A; Gilbreath, J; Khoury, P; Kontoyiannis, DP; Papadakis, K; Pinczowski, H; Raad, II; Uzun, O; Vartivarian, SE, 1996) |
| "In patients without neutropenia and without major immunodeficiency, fluconazole and amphotericin B are not significantly different in their effectiveness in treating candidemia." | 9.07 | A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. ( Bennett, JE; Dine, AP; Edwards, JE; Karchmer, AW; Pappas, PG; Rex, JH; Scheld, WM; Sugar, AM; van der Horst, CM; Washburn, RG, 1994) |
| " Terms such as micafungin, aspergillosis, zygomycosis, invasive fungal infections, emerging fungal infections, antifungal treatment or therapy, antifungal prophylaxis, empiric or pre-emptive therapy were crossed." | 8.85 | [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi]. ( Salavert-Lletí, M; Zaragoza-Crespo, R, 2009) |
| "A patient with ALL on anticancer chemotherapy developed fever which was later attributed to be due to Fusarium fungemia." | 8.81 | Fusarium solani fungemia in a patient with acute lymphoblastic leukemia. ( Appaji, L; Shafiulla, M; Sridhar, H; Subramanyam, JR; Vijaykumar, BR, 2001) |
| "This study highlights that prophylactic fluconazole may be an associated factor of Malassezia colonization; M furfur remains a potential concern for fungemia in the care of premature infants and thus requires our attention." | 7.96 | Malassezia furfur Emergence and Candidemia Trends in a Neonatal Intensive Care Unit During 10 Years: The Experience of Fluconazole Prophylaxis in a Single Hospital. ( Chen, CC; Chen, IT; Huang, HC; Kuo, KC, 2020) |
| "We describe the microbiological characterization and clinical presentation of two fungemia cases caused by fluconazole-resistant Candida auris in neonatal intensive care unit of a hospital in Beijing, China." | 7.88 | Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China. ( Chen, J; Chen, Y; Fan, W; Han, L; Liu, J; Qi, L; Wang, Z; Xia, X; Zhang, L; Zhao, J, 2018) |
| ", with that of amphotericin B, caspofungin and fluconazole, in an immunocompetent murine model of haematogenously disseminated candidiasis caused by a fluconazole-resistant Candida albicans." | 7.74 | Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis. ( Ghannoum, MA; Kim, HG; Long, L, 2007) |
| "We report on the correlation of the outcomes for two cohorts of patients who had been treated for candidemia (126 episodes) or oropharyngeal candidiasis (110 episodes) with various doses of fluconazole and the MIC of fluconazole obtained by using the EUCAST standard for fermentative yeasts." | 7.74 | Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia. ( Almirante, B; Cuenca-Estrella, M; Donnelly, JP; Laguna, F; Mouton, JW; Pahissa, A; Rodríguez-Pardo, D; Rodríguez-Tudela, JL, 2007) |
| "We report on a case of fungemia due to fluconazole-resistant Candida nivariensis (MIC, > or =128 microg/ml)." | 7.74 | Catheter-related fungemia due to fluconazole-resistant Candida nivariensis. ( Fujita, S; Kawano, M; Okusi, T; Ota, Y; Senda, Y; Takada, H; Yamada, K, 2007) |
| "We report a case of breakthrough invasive zygomycosis in a stem cell transplant recipient who was receiving caspofungin for treatment of a breakthrough Candida krusei fungemia that occurred during fluconazole prophylaxis." | 7.73 | Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation. ( Barberi, W; Foà, R; Girmenia, C; Iori, AP; Martino, P; Micozzi, A; Moleti, ML, 2005) |
| "A 7-year retrospective analysis of candidemia in patients with hematologic malignancies demonstrated that ten patients, who received itraconazole and fluconazole during neutropenia, developed breakthrough fungemia caused by fluconazole-resistant Candida albicans (C." | 7.73 | Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies. ( Kyo, T; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T, 2006) |
| "(1) To determine the pharmacokinetics of sequential intravenous and enteral fluconazole in the serum of surgical intensive care unit (ICU) patients with deep mycoses." | 7.71 | Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function. ( Bruining, HA; Buijk, SL; Gyssens, IC; Mouton, JW; Touw, DJ; Verbrugh, HA, 2001) |
| "To assess efficacy and safety of fluconazole in neonates with Candida fungemia." | 7.70 | Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis. ( Filka, J; Hartmanova, I; Huttova, M; Kralinsky, K; Krcmery, V; Krizan, S; Kurak, J; Uher, J, 1998) |
| " and 10 non-Candida yeasts) recovered from 169 surgical, neonatal, critically ill intensive care unit patients (ICU), and cancer patients (mixed patient population) to amphotericin B (AmB), fluconazole (FLU), 5-flucytosine (5-FC), itraconazole (ITRA), ketoconazole (KETO), miconazole (MICO), and nystatin (NYS), in order to correlate in-vitro resistance to fluconazole with the outcome of fungemia." | 7.70 | Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia? ( Bille, J; Hanzen, J; Kovacicova, G; Krcmery, V; Krupova, Y; Lamosova, M; Liskova, A; Lovaszova, M; Macekova, L; Milosovic, P; Obertik, T; Purgelova, A; Roidova, A; Szovenyiova, Z; Trupl, J, 2000) |
| "In order to verify whether fluconazole has a prophylactive effect against the occurrence of cryptococcosis in HIV-infected patients and to identify other factors capable of increasing or reducing the risk of this infection, we arranged a case-control study of 17 patients with cryptococcal infection." | 7.69 | Fluconazole for primary prophylaxis of AIDS-associated cryptococcosis: a case-control study. ( Ammassari, A; Antinori, A; Linzalone, A; Marasca, G; Morace, G; Murri, R, 1995) |
| "The present studies were performed to determine whether any beneficial interaction results from combination therapy with recombinant human granulocyte colony-stimulating factor (GCSF) and fluconazole in disseminated candidiasis in mice." | 7.69 | Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis. ( Bocanegra, R; Graybill, JR; Luther, M, 1995) |
| "Fluconazole was given empirically, but had no effect." | 6.45 | Fluconazole-resistant Kodamaea ohmeri fungemia associated with cellulitis: case report and review of the literature. ( Hou, SJ; Lee, SY; Lu, JJ; Peng, MY; Sun, JR; Yang, BH, 2009) |
| "Invasive trichosporonosis is a rare and lethal fungal infection that occurs in immunocompromised patients." | 5.62 | Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma. ( Itoh, K; Iwasaki, H; Negoro, E; Shigemi, H; Tokimatsu, I; Tsutani, H; Yamauchi, T, 2021) |
| " The usefulness of fluconazole therapy, the best dosage regimen and the in vitro and in vivo correlations are discussed." | 5.31 | [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report]. ( Clavier, H; Kalfon, P; Mebtouche, B; Thomas, F, 2000) |
| " krusei breakthrough infections was similar to what is seen with high-dose fluconazole (400 mg) prophylaxis, and no adverse effects of low-dose fluconazole in terms of increased incidence of non-susceptible Candida species was seen." | 5.31 | Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. ( Henslee-Downey, JP; Mehta, J; Safdar, A; Singhal, S; van Rhee, F, 2001) |
| " dermatitidis fungemia in a premature extremely low birth weight (ELBW) neonate who succumbed despite antifungal therapy with liposomal amphotericin (AMB) and fluconazole." | 5.22 | A fatal neonatal case of fungemia due to Exophiala dermatitidis-case report and literature review. ( Demetriou, M; Falaina, V; Meletiadis, J; Mpakosi, A; Siopi, M; Theodoraki, M, 2022) |
| "To determine whether Candida glabrata colonization and invasive candidiasis (IC) increased among critically ill surgical patients 3 years after the introduction of fluconazole prophylaxis to a surgical intensive care unit (SICU)." | 5.14 | The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial. ( Colantuoni, EA; Fothergill, AW; Hendrix, CW; Lipsett, PA; Magill, SS; Merz, WG; Shields, CE; Swoboda, SM, 2009) |
| "To see whether empirical fluconazole improves clinical outcomes more than placebo in adult ICU patients at high risk for invasive candidiasis." | 5.13 | Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial. ( Biswas, P; Darouiche, RO; Edwards, JE; Hadley, S; Karchmer, AW; Panzer, H; Rex, JH; Schuster, MG; Slotman, G; Sobel, JD, 2008) |
| " We compared anidulafungin with fluconazole in a randomized, double-blind, noninferiority trial of treatment for invasive candidiasis." | 5.12 | Anidulafungin versus fluconazole for invasive candidiasis. ( Betts, R; Chapman, SW; Goldstein, BP; Kett, DH; Krause, DS; Kumar, D; Pappas, PG; Reboli, AC; Rotstein, C; Schranz, J; Walsh, TJ; Wible, M, 2007) |
| "Itraconazole was as effective as fluconazole in nosocomial candidiasis in children receiving intensive care and was devoid of serious side effects." | 5.11 | Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study. ( Chakrabarti, A; M, J; Mondal, RK; Singhi, SC, 2004) |
| "To compare the efficacy and toxicity of fluconazole and amphotericin B in the treatment of hematogenous candidiasis in cancer patients." | 5.08 | Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study. ( Abi-Said, D; Anaissie, EJ; Bodey, GP; Gardner, A; Gilbreath, J; Khoury, P; Kontoyiannis, DP; Papadakis, K; Pinczowski, H; Raad, II; Uzun, O; Vartivarian, SE, 1996) |
| "In patients without neutropenia and without major immunodeficiency, fluconazole and amphotericin B are not significantly different in their effectiveness in treating candidemia." | 5.07 | A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute. ( Bennett, JE; Dine, AP; Edwards, JE; Karchmer, AW; Pappas, PG; Rex, JH; Scheld, WM; Sugar, AM; van der Horst, CM; Washburn, RG, 1994) |
| "Efficacies of fluconazole (FLCZ) were evaluated in 8 cases of systemic mycosis (1 case each of candidemia, candiduria, 4 cases of pulmonary candidiasis, and 2 cases of suspected fungemia) complicated in immunocompromised children." | 5.07 | [A clinical study of fluconazole in the treatment of systemic mycosis associated with immunocompromised children]. ( Hatae, Y; Ishikawa, A; Ishikawa, Y; Matsumoto, S; Sakiyama, Y; Shimizu, T; Takase, A; Takeda, T; Wagatsuma, Y, 1994) |
| " Terms such as micafungin, aspergillosis, zygomycosis, invasive fungal infections, emerging fungal infections, antifungal treatment or therapy, antifungal prophylaxis, empiric or pre-emptive therapy were crossed." | 4.85 | [Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi]. ( Salavert-Lletí, M; Zaragoza-Crespo, R, 2009) |
| " Although fluconazole use has been considered one of the main causes for the epidemiologic change in invasive candidiasis, especially in the increase of species less sensitive to this agent, this association remains unproven." | 4.84 | [Current treatment of candidemia. Role of anidulafungin]. ( Almirante, B; Pemán, J, 2008) |
| "Prophylactic fluconazole administration for prevention of mycoses in SICU patients appears to successfully decrease the rate of these infections, but this strategy does not improve survival." | 4.82 | Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis. ( Chung, K; Jackson, WL; Kollef, MH; Shorr, AF; Waterman, PE, 2005) |
| "A patient with ALL on anticancer chemotherapy developed fever which was later attributed to be due to Fusarium fungemia." | 4.81 | Fusarium solani fungemia in a patient with acute lymphoblastic leukemia. ( Appaji, L; Shafiulla, M; Sridhar, H; Subramanyam, JR; Vijaykumar, BR, 2001) |
| " Therapeutic usage of amphotericin B, the agent of choice for serious Candida infection, is reviewed, along with usage of 5-flucytosine and fluconazole." | 4.78 | Pathogenesis and management of Candida infection syndromes in non-neutropenic patients. ( Solomkin, JS, 1993) |
| " Amphotericin B remains the agent of choice for treatment of hematogenously disseminated candidiasis and for candidemia, although the optimal dosage and duration of this therapy are poorly defined." | 4.78 | Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients. ( Edwards, JE; Filler, SG, 1992) |
| "Several institutions reported a rise not only in fungemia incidence but also in the number of cases caused by Candida auris or fluconazole-resistant C." | 4.31 | Yeasts from blood cultures in the wake of the COVID-19 pandemic in a tertiary care hospital: Shift in species epidemiology, steady low antifungal resistance and full in vitro ibrexafungerp activity. ( Díaz-García, J; Escribano, P; Guinea, J; Machado, M; Mesquida, A; Muñoz, P; Sánchez-Carrillo, C, 2023) |
| "This study highlights that prophylactic fluconazole may be an associated factor of Malassezia colonization; M furfur remains a potential concern for fungemia in the care of premature infants and thus requires our attention." | 3.96 | Malassezia furfur Emergence and Candidemia Trends in a Neonatal Intensive Care Unit During 10 Years: The Experience of Fluconazole Prophylaxis in a Single Hospital. ( Chen, CC; Chen, IT; Huang, HC; Kuo, KC, 2020) |
| "We describe the microbiological characterization and clinical presentation of two fungemia cases caused by fluconazole-resistant Candida auris in neonatal intensive care unit of a hospital in Beijing, China." | 3.88 | Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China. ( Chen, J; Chen, Y; Fan, W; Han, L; Liu, J; Qi, L; Wang, Z; Xia, X; Zhang, L; Zhao, J, 2018) |
| "Recent studies of nonneutropenic patients with candidemia or candidiasis suggest that fluconazole pharmacodynamic parameters correlate with clinical outcomes; however, additional data of correlation to mortality in patients with candidemia would be valuable." | 3.74 | Association of fluconazole pharmacodynamics with mortality in patients with candidemia. ( Andes, DR; Baddley, JW; Bhavnani, SM; Moser, SA; Patel, M, 2008) |
| ", with that of amphotericin B, caspofungin and fluconazole, in an immunocompetent murine model of haematogenously disseminated candidiasis caused by a fluconazole-resistant Candida albicans." | 3.74 | Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis. ( Ghannoum, MA; Kim, HG; Long, L, 2007) |
| "We report on the correlation of the outcomes for two cohorts of patients who had been treated for candidemia (126 episodes) or oropharyngeal candidiasis (110 episodes) with various doses of fluconazole and the MIC of fluconazole obtained by using the EUCAST standard for fermentative yeasts." | 3.74 | Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia. ( Almirante, B; Cuenca-Estrella, M; Donnelly, JP; Laguna, F; Mouton, JW; Pahissa, A; Rodríguez-Pardo, D; Rodríguez-Tudela, JL, 2007) |
| "We report a case of breakthrough invasive zygomycosis in a stem cell transplant recipient who was receiving caspofungin for treatment of a breakthrough Candida krusei fungemia that occurred during fluconazole prophylaxis." | 3.73 | Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation. ( Barberi, W; Foà, R; Girmenia, C; Iori, AP; Martino, P; Micozzi, A; Moleti, ML, 2005) |
| " The patient has no identified sequelae at 6-month follow-up and continues on long-term fluconazole therapy for candida endocarditis." | 3.73 | Survival of candida sepsis in extracorporeal membrane oxygenation. ( Ibsen, LM; Minette, MS, 2005) |
| "A 7-year retrospective analysis of candidemia in patients with hematologic malignancies demonstrated that ten patients, who received itraconazole and fluconazole during neutropenia, developed breakthrough fungemia caused by fluconazole-resistant Candida albicans (C." | 3.73 | Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies. ( Kyo, T; Mikami, Y; Murayama, SY; Myoken, Y; Sugata, T, 2006) |
| "We evaluated whether the likelihood of developing invasive candidiasis (IC) differed depending upon the anatomic site of Candida colonization in 182 surgical intensive care unit (SICU) patients who participated in a randomized trial of fluconazole to prevent candidiasis." | 3.73 | The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients. ( Hendrix, CW; Johnson, EA; Lipsett, PA; Magill, SS; Merz, WG; Pelz, RK; Swoboda, SM, 2006) |
| "Fluconazole is an antifungal agent that is widely used for the treatment of Candida infection." | 3.73 | Effect of fluconazole consumption on long-term trends in candidal ecology. ( Blot, S; Buyle, F; Claeys, G; De Waele, JJ; Hoste, E; Janssens, R; Peleman, R; Vandewoude, K; Vogelaers, D, 2006) |
| "A 22-yr-old male with acute lymphoblastic leukemia and Candida krusei fungemia failed therapy with fluconazole and amphotericin B." | 3.72 | Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent. ( McGee, WT; Tereso, GJ, 2003) |
| "(1) To determine the pharmacokinetics of sequential intravenous and enteral fluconazole in the serum of surgical intensive care unit (ICU) patients with deep mycoses." | 3.71 | Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function. ( Bruining, HA; Buijk, SL; Gyssens, IC; Mouton, JW; Touw, DJ; Verbrugh, HA, 2001) |
| "We describe a case of Acremonium falciforme fungemia under treatment of fluconazole." | 3.71 | Case Report. Acremonium falciforme fungemia in a patient with acute leukaemia. ( Erdem, F; Nedret Koç, A; Patiroğlu, T, 2002) |
| "To assess efficacy and safety of fluconazole in neonates with Candida fungemia." | 3.70 | Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis. ( Filka, J; Hartmanova, I; Huttova, M; Kralinsky, K; Krcmery, V; Krizan, S; Kurak, J; Uher, J, 1998) |
| "Few data exist concerning the combined use of fluconazole systemically and as an irrigant for nephrostomy tubes in a patient with renal candidiasis." | 3.70 | The use of fluconazole as a local irrigant for nephrostomy tubes. ( Clark, MA; Czachor, JS; Gaunt, T, 1999) |
| "Candida krusei is inherently resistant to fluconazole and is emerging as a frequent cause of fungemia in patients with hematologic malignant neoplasms." | 3.70 | Candida krusei fungemia. An escalating serious infection in immunocompromised patients. ( Abbas, J; Abi-Said, D; Bodey, GP; Girgawy, E; Hachem, R; Hanna, HA; Mardani, M; Raad, I; Whimbey, E, 2000) |
| " and 10 non-Candida yeasts) recovered from 169 surgical, neonatal, critically ill intensive care unit patients (ICU), and cancer patients (mixed patient population) to amphotericin B (AmB), fluconazole (FLU), 5-flucytosine (5-FC), itraconazole (ITRA), ketoconazole (KETO), miconazole (MICO), and nystatin (NYS), in order to correlate in-vitro resistance to fluconazole with the outcome of fungemia." | 3.70 | Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia? ( Bille, J; Hanzen, J; Kovacicova, G; Krcmery, V; Krupova, Y; Lamosova, M; Liskova, A; Lovaszova, M; Macekova, L; Milosovic, P; Obertik, T; Purgelova, A; Roidova, A; Szovenyiova, Z; Trupl, J, 2000) |
| "The in vitro activity of amphotericin B, flucytosine and fluconazole against 95 yeasts causing fungemia in a single institution over the last eight years was determined by a broth macromethod recommended by the National Committee for Clinical Laboratory Standards." | 3.69 | In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections. ( Berenguer, J; Bouza, E; Fernández-Baca, V; Sánchez, R, 1995) |
| "In order to verify whether fluconazole has a prophylactive effect against the occurrence of cryptococcosis in HIV-infected patients and to identify other factors capable of increasing or reducing the risk of this infection, we arranged a case-control study of 17 patients with cryptococcal infection." | 3.69 | Fluconazole for primary prophylaxis of AIDS-associated cryptococcosis: a case-control study. ( Ammassari, A; Antinori, A; Linzalone, A; Marasca, G; Morace, G; Murri, R, 1995) |
| "The present studies were performed to determine whether any beneficial interaction results from combination therapy with recombinant human granulocyte colony-stimulating factor (GCSF) and fluconazole in disseminated candidiasis in mice." | 3.69 | Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis. ( Bocanegra, R; Graybill, JR; Luther, M, 1995) |
| "Infections with fluconazole-resistant Candida albicans isolate have rarely been described in clinical settings other than oropharyngeal candidiasis in patients with late-stage AIDS." | 3.69 | Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia. ( Dix, S; Falconer, DJ; Geller, R; Gilmore, C; Nolte, FS; Parkinson, T; Williams, J; Wingard, JR, 1997) |
| "We report on two children with malignancy who showed fungemia despite the antifungal treatment with fluconazole." | 3.69 | [Phagocytosis of fungi in the peripheral blood neutrophils of two children with cancer during treatment with fluconazole]. ( Ebihara, Y; Hosoya, R; Manabe, A; Saito, A; Takahashi, K, 1997) |
| " Fluconazole has been proposed as alternative therapy for the treatment of systemic candidiasis including candidemia." | 3.68 | Persistence of the same Candida albicans strain despite fluconazole therapy. Documentation by pulsed-field gel electrophoresis. ( Blumberg, HM; Hendershot, EF; Lott, TJ, 1992) |
| "Both cancer centers differed in prophylactic antibiotic policies." | 2.69 | Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome. ( Foltinova, A; Kaiserova, E; Kiskova, M; Kovacicova, G; Krchnakova, A; Krcmery, V; Krupova, I; Kunova, A; Trupl, J; West, D, 1998) |
| "Fluconazole (FLU) is an alternative to amphotericin B (AMB) for the treatment of candidemia in non-neutropenic patients." | 2.69 | Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients. ( Conly, J; Dranitsaris, G; Garber, G; Ioannou, S; Miller, M; Phillips, P; Puodziunas, A; Rotstein, C; Salit, I; Shafran, S; Singer, J; Smaill, F; Williams, K, 1998) |
| "Amphotericin B was prescribed therapeutically in 25 patients, in seven together with fluconazole." | 2.68 | Management of candida septicaemia in a regional burn unit. ( Belcher, K; Law, EJ; Still, JM, 1995) |
| "amphotericin B for the treatment of disseminated fungal sepsis in neonates." | 2.68 | Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial. ( Cooper, PA; De Villiers, FP; Driessen, M; Ellis, JB; Gous, H; Hahn, D; Muwazi, F; Wainer, S, 1996) |
| "Fluconazole alone was given to 27 patients, amphotericin B alone to 10, and sequential therapy to 6." | 2.68 | Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU. ( Ibáñez-Lucía, P; León-Gil, C; León-Regidor, MA; Martínez-González, J; Nolla-Salas, J; Sitges-Serra, A; Torres-Rodríguez, JM, 1997) |
| " No treatment-related adverse events required termination of treatment." | 2.67 | Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients. Multicentre Study Group. ( Graninger, W; Presterl, E, 1994) |
| "Fluconazole treatment was successful in 53% of the patients." | 2.67 | Efficacy of fluconazole in the treatment of systemic fungal infections. ( Milatovic, D; Voss, A, 1992) |
| "Presentation with pleural effusion is rare in cryptococcal disease; in fact, only 4 cases of pleural effusion as the initial clinical presentation in cryptococcosis have been reported in English-language literature to date." | 2.52 | Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review. ( Chen, D; Chen, M; Dai, C; Huang, X; Li, Y; Wang, L; Wang, X; Xu, X; Yang, L; Yao, D; Yu, C; Yu, X, 2015) |
| "Fungemia is a serious problem within neonatal intensive care units around the world." | 2.50 | Fungal prophylaxis in neonates: a review article. ( Bradshaw, WT; Lollis, TR, 2014) |
| "Fluconazole was given empirically, but had no effect." | 2.45 | Fluconazole-resistant Kodamaea ohmeri fungemia associated with cellulitis: case report and review of the literature. ( Hou, SJ; Lee, SY; Lu, JJ; Peng, MY; Sun, JR; Yang, BH, 2009) |
| "Candida species rarely cause spondylodiscitis." | 2.42 | An unusual cause of vertebral osteomyelitis: Candida species. ( Bouchuiguir-Wafa, K; Garbino, J; Lew, D; Rohner, P; Schnyder, I, 2003) |
| " This article reviews recent pertinent data with regard to dosing guidelines, efficacy, and toxicities of available systemic antifungal agents in the newborn." | 2.42 | Antifungal pharmacotherapy for neonatal candidiasis. ( Bliss, JM; Gigliotti, F; Wellington, M, 2003) |
| "Invasive candidiasis is a frequent infection in compromised patient." | 2.41 | [Visceral candidiasis]. ( Herbrecht, R; Letscher-Bru, V; Zamfir, A, 2001) |
| "All three infections appeared in cancer patients presented with fungaemia, one additionally with meningitis." | 2.40 | Invasive infections due to Clavispora lusitaniae. ( Grausova, S; Hanzen, J; Krcmery, V; Kunova, A; Mateicka, F, 1999) |
| "krusei fungemia from our cancer institute." | 2.40 | Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review. ( Grausova, S; Grey, E; Krcmery, V; Krupova, I; Kunova, A; Mateicka, F; Pichnova, E; Sabo, A; Spanik, S; Trupl, J, 1999) |
| "Fluconazole is an effective treatment for cryptococcal meningitis." | 2.39 | The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection. ( Cartledge, J; Fisher, M; Gazzard, BG; Nelson, MR; Rogers, T, 1994) |
| "Amphotericin B has routinely been used to treat this infection." | 2.39 | Problems and controversies in the management of hematogenous candidiasis. ( Anaissie, EJ; Uzun, O, 1996) |
| "In 60% of the cases, candidal spondylodiskitis was a late complication of candidemia (mean delay, 5." | 2.39 | Spondylodiskitis due to Candida albicans: report of two patients who were successfully treated with fluconazole and review of the literature. ( Bourée, P; Charpentier, B; Dupont, B; Hennequin, C; Hiesse, C, 1996) |
| "Over a 12 year period 19 children treated for leukemia at our institution developed C." | 2.38 | Candida tropicalis infections in children with leukemia. ( Flynn, PM; Hughes, WT; Marina, NM; Rivera, GK, 1993) |
| "melanogenum fungemia is difficult as it is easily confused with Candida species in Gram stained smears and similar colony morphology during the initial stages of growth." | 1.91 | First case of neonatal fungemia caused by Aureobasidium melanogenum. ( Samaddar, A; Sharma, A, 2023) |
| "Invasive trichosporonosis is a rare and lethal fungal infection that occurs in immunocompromised patients." | 1.62 | Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma. ( Itoh, K; Iwasaki, H; Negoro, E; Shigemi, H; Tokimatsu, I; Tsutani, H; Yamauchi, T, 2021) |
| "The fluconazole therapy was replaced with micafungin on day 26 and the patient exhibited improvements." | 1.56 | Case report: nosocomial fungemia caused by Candida diddensiae. ( Choi, YJ; Jung, SI; Kim, SE; Park, KH; Shin, JH; Won, EJ, 2020) |
| "Cryptococcal meningitis is a fungal infection that is most commonly thought of as an opportunistic infection affecting immunocompromised patients, classically patients with Human Immunodeficiency (HIV) infection." | 1.56 | Cryptococcal meningitis in an immunocompetent patient. ( Lacy, AJ; Murphy, LS; Shah, KS; Smith, AT, 2020) |
| "Fluconazole was administrated for one year." | 1.56 | Candidal Prosthetic Hip Infection in a Patient with Previous Candidal Sepsis - A Case Report. ( Murata, Y; Ohnishi, H; Okabe, S; Sakai, A; Tamagawa, S, 2020) |
| "Neonatal invasive candidiasis has worse outcomes than non-neonatal pediatric candidiasis." | 1.48 | Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates. ( Chiang, MC; Chu, SM; Fu, RH; Hsu, JF; Huang, HR; Lai, MY; Lee, CW; Lee, IT; Tsai, MH; Wu, IH, 2018) |
| "S." | 1.46 | Fatal course of Saprochaete capitata fungemia in children with acute lymphoblastic leukemia. ( Bör, Ö; Bozkurt Turhan, A; Dinleyici, ÇE; Düzenli Kar, Y; Özdemir, ZC, 2017) |
| "Cryptococcosis is a potentially severe infection that usually occurs in a setting of immunosuppression." | 1.43 | [Multiple facial nodules revealing disseminated cryptococcosis in an immunocompetent patient]. ( Benzekri, A; Benzekri, L; Hassam, B; Ismaili, N; Lyagoubi, M; Mansouri, S; Rachadi, H; Ramli, I; Senouci, K, 2016) |
| "One patient developed Fusarium infection." | 1.40 | Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country. ( Adil, SN; Ali, N; Shaikh, MU, 2014) |
| "Micafungin was started empirically." | 1.40 | Fungemia due to Lachancea fermentati: a case report. ( Green, JS; Leuck, AM; Rothenberger, MK, 2014) |
| "Coccidioidomycosis is an insidious fungal disease, endemic to arid regions of the Americas, which is becoming more frequently recognised worldwide." | 1.40 | Beyond the superficial: Coccidioides immitis fungaemia in a man with fever, fatigue and skin nodules: a case of an emerging and evolving pathogen. ( Baxi, SM; Chin-Hong, P; Iribarne, D; Langelier, C, 2014) |
| "Clinical oral mucositis screenings were performed triweekly." | 1.39 | Microbiology and epidemiology of oral yeast colonization in hemopoietic progenitor cell transplant recipients. ( Freytes, CO; Kirkpatrick, WR; Patterson, TF; Redding, SW; Toro, JJ; Westbrook, SD; Wiederhold, NP, 2013) |
| "Treatment with fluconazole, itraconazole and amphotericin B upon detection of C." | 1.38 | Long-term surveillance and treatment of subclinical cryptococcosis and nasal colonization by Cryptococcus neoformans and C. gattii species complex in captive koalas (Phascolarctes cinereus). ( Kamegaya, C; Kido, N; Makimura, K; Omiya, T; Shibata, E; Shindo, I; Yamamoto, Y, 2012) |
| "Fluconazole resistance was detected in C." | 1.36 | The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study. ( Chee, CW; Ng, LS; Tan, AL; Tan, TY; Tee, NW, 2010) |
| "glabrata fungemia were systematically recorded." | 1.36 | Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients. ( Adrie, C; Clec'h, C; Cohen, Y; Gauzit, R; Karoubi, P; Marsepoil, T; Zarka, D, 2010) |
| "Fluconazole (37." | 1.36 | Cutaneous cryptococcosis in solid organ transplant recipients. ( Alexander, BD; Del Busto, R; Dowdy, LA; Dromer, F; Fisher, RA; Forrest, GN; Garcia-Diaz, J; Gupta, KL; House, AA; Houston, SH; Humar, A; Huprikar, S; Husain, S; John, GT; Johnson, LB; Kalil, AC; Klintmalm, GB; Limaye, AP; Lortholary, O; Lyon, GM; Morris, MI; Muñoz, P; Orloff, SL; Pruett, TL; Pursell, K; Razonable, RR; Sifri, CD; Singh, N; Somani, J; Stosor, V; Sun, HY; Wagener, MM; Wray, D, 2010) |
| "Candidaemia in cancer patients is associated with increasing fluconazole resistance." | 1.36 | Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death. ( Chen, SC; Ellis, DH; Marriott, D; Morrissey, CO; Nguyen, Q; Slavin, MA; Sorrell, TC; Thursky, KA, 2010) |
| "Galactosemia is one of the rare inborn errors of metabolism, which if detected early can be treated effectively." | 1.36 | Association of fungal sepsis and galactosemia. ( Bharti, B; Inusha, P; Verma, S, 2010) |
| "027), inadequate initial fluconazole dosing (AOR, 3." | 1.35 | Treatment-related risk factors for hospital mortality in Candida bloodstream infections. ( Kollef, MH; Labelle, AJ; Micek, ST; Roubinian, N, 2008) |
| "No fluconazole resistance was observed in C." | 1.35 | Neonatal candidaemia in Kuwait: a 12-year study of risk factors, species spectrum and antifungal susceptibility. ( Al-Sweih, N; Devarajan, LV; Khan, S; Khan, Z, 2009) |
| "Fluconazole was discontinued in two patients due to non-severe adverse events (acute eosinophilia, elevated transaminases)." | 1.35 | Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit. ( Campos, T; Faiz, S; Neale, B; Ostrosky-Zeichner, L; Parsley, E; Patel, B; Rios, E, 2009) |
| "05) or inadequately dosed fluconazole (32% versus 8%, P < 0." | 1.35 | Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection. ( Diekema, DJ; Horn, DL; Klevay, MJ; Neofytos, D; Pfaller, MA, 2009) |
| "Fluconazole was the most commonly administered antimicrobial, followed by the echinocandins, and amphotericin B products were infrequently administered." | 1.35 | Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. ( Anaissie, EJ; Chang, CH; Fishman, JA; Horn, DL; Marr, KA; Neofytos, D; Olyaei, AJ; Pfaller, MA; Steinbach, WJ; Webster, KM, 2009) |
| "Fluconazole was used as prophylaxis in critically ill patients until 2002; from January 2003 infectious disease consultants strongly discouraged its use." | 1.35 | Incidence of candidaemia and relationship with fluconazole use in an intensive care unit. ( Ansaldi, F; Bassetti, M; Bobbio Pallavicini, F; Icardi, G; Malfatto, E; Molinari, MP; Mussap, M; Nicolini, L; Rebesco, B; Viscoli, C, 2009) |
| "Voriconazole was very active in vitro against C." | 1.35 | Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre. ( Alkorta, M; Eraso, E; Hernández-Almaraz, JL; Quindós, G; Sánchez-Vargas, LO; Villar-Vidal, M, 2008) |
| "Neutropenia was the leading risk factor for all candidemia, whereas the catheter was the leading risk factor for C." | 1.35 | The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. ( Hachem, R; Hanna, H; Jiang, Y; Kontoyiannis, D; Raad, I, 2008) |
| "Fluconazole MICs were highest against C." | 1.34 | Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia. ( Garey, KW; Pai, MP; Turpin, RS, 2007) |
| " However, the extent to which inappropriate antifungal therapy is due to improper dosing or drug selection has not been well investigated." | 1.34 | Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines. ( Bearden, DT; Garey, KW; Mingo, DE; Pai, MP; Rege, MD; Suda, KJ; Turpin, RS, 2007) |
| "Fluconazole prophylaxis has been used to control the problem." | 1.33 | Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit. ( Koukila-Kähkölä, P; Luukkainen, P; Lyytikäinen, O; Pfaller, MA; Pujol, C; Richardson, M; Sarvikivi, E; Saxén, H; Soll, DR, 2005) |
| "Fluconazole has been used as prophylaxis against systemic fungal infections in preterm neonates." | 1.33 | Effects of cessation of a policy of neonatal fluconazole prophylaxis on fungal resurgence. ( Chakrabarti, A; Dutta, S; Murki, S; Narang, A; Varma, S, 2005) |
| "Trichosporon fungemia is usually seen in neutropenic patients with underlying hematological malignancies." | 1.33 | Trichosporon asahii fungemia in a patient with non-hematological malignancy. ( Ince, N; Kandirali, E; Karabay, O; Kocoglu, E; Madariaga, MG, 2006) |
| "Fluconazole was the most frequently prescribed antifungal (1846 patient-days) followed by amphotericin B deoxycholate (251 patient-days), lipid formulations of amphotericin B (201 patient-days), itraconazole (71 patient-days), and caspofungin (42 patient-days)." | 1.33 | Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study. ( Bearden, DT; Cannon, JP; Garey, KW; Gentry, LO; Kontoyiannis, DP; Lewis, RE; Neuhauser, MM, 2006) |
| "Fluconazole resistance was detected in one isolate of C." | 1.33 | Epidemiology of candidemia in a Turkish tertiary care hospital. ( Bakir, M; Barton, R; Cerikcioglu, N; Yagci, A, 2006) |
| "Infectious diarrhea is common in cases of ulcerative colitis (UC), caused by resistance to treatment." | 1.32 | Saccharomyces cerevisiae-associated diarrhea in an immunocompetent patient with ulcerative colitis. ( Armuzzi, A; Candelli, M; Gasbarrini, A; Gasbarrini, G; Nestola, M; Nista, EC; Silveri, NG, 2003) |
| "The isolation of Candida sp in nosocomial infections is on the increase and over the past 10 years many guidelines for "good" practices and recommendations have been published on the modalities for the management of systemic candidiasis." | 1.32 | [Infections by Candida sp. in intensive care. Survey of French practices]. ( Blin, P; Chevalier, E; Cohen, Y; Dupont, H; Gauzit, R; Hennequin, C; Montravers, P; Palestro, B; Timsit, JF; Veber, B, 2003) |
| "Anderson Cancer Center (1998-2002)." | 1.32 | High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study. ( Kontoyiannis, DP; Rolston, KV; Torres, HA, 2004) |
| "Fluconazole was the antifungal agent most frequently used, both in infected and colonized patients." | 1.32 | [Indications for antifungal treatment in intensive care unit patients]. ( Alvarez-Lerma, F; Bermejo, B; Cerdá, E; León, C; Olaechea, P; Palomar, M, 2004) |
| "Fluconazole prophylaxis was not used during the study period." | 1.32 | Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis. ( Anttila, VJ; Jantunen, E; Juvonen, E; Nihtinen, A; Parkkali, T; Ruutu, T; Volin, L, 2004) |
| "Fluconazole resistance was more common among C." | 1.31 | Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York City (C ( Armstrong, D; Chaturvedi, V; Koll, BS; Larone, DH; Perlin, DS; Safdar, A, 2002) |
| "Fluconazole MICs were 16 (3 SDD strains) and 128 microg/ml (1 resistant strain), respectively." | 1.31 | Frequency and clinical significance of bloodstream infections caused by C albicans strains with reduced susceptibility to fluconazole. ( Alcalá, L; Bouza, E; Fernández-Turégano, CP; Muñoz, P; Peláez, T; Rodríguez-Créixems, M, 2002) |
| " The level of resistance to fungal infections was superior to that given by fluconazole (FLC) treatment alone and highly enhanced by the combination with FLC." | 1.31 | Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections. ( Endo, M; Ino-Ue, T; Kato, I; Kurasawa, M; Mizutani, S; Saito, H; Takesako, K; Uno, Y, 2000) |
| " The usefulness of fluconazole therapy, the best dosage regimen and the in vitro and in vivo correlations are discussed." | 1.31 | [Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report]. ( Clavier, H; Kalfon, P; Mebtouche, B; Thomas, F, 2000) |
| "Fluconazole was administered as the first line agent in 6 episodes and successfully cleared candidemia in 5 episodes." | 1.31 | Fluconazole therapy in neonatal candidemia. ( Chou, YH; Hsieh, WS; Huang, YC; Kuo, CY; Lien, RI; Lin, TY; Yang, PH, 2000) |
| "Fluconazole was effective as a single agent in 3 patients with solid tumors." | 1.31 | Candida lusitaniae: a cause of breakthrough fungemia in cancer patients. ( Hachem, R; Minari, A; Raad, I, 2001) |
| " krusei breakthrough infections was similar to what is seen with high-dose fluconazole (400 mg) prophylaxis, and no adverse effects of low-dose fluconazole in terms of increased incidence of non-susceptible Candida species was seen." | 1.31 | Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome. ( Henslee-Downey, JP; Mehta, J; Safdar, A; Singhal, S; van Rhee, F, 2001) |
| "Fluconazole was less effective against C." | 1.31 | The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. ( Abbas, J; Bodey, GP; Boktour, M; Girgawy, E; Hachem, RY; Hanna, HA; Kontoyiannis, DP; Mardani, M; Raad, II, 2002) |
| "Fluconazole was used before the onset of candidemia in only two patients." | 1.31 | Nosocomial candidemia in a tertiary care hospital in Saudi Arabia. ( Bukharie, HA, 2002) |
| "A 57-year-old male was treated for fungal endocarditis caused by Candida parapsilosis which precipitated severe cardiac valve vegetation and insufficiency." | 1.30 | A case report of Candida parapsilosis endocarditis. ( Inoue, Y; Kawada, S; Ueda, T; Yozu, R, 1998) |
| "Oral fluconazole seems to be a safe and effective treatment for Candida albicans septicaemia even in premature infants." | 1.30 | Pharmacokinetics of oral fluconazole in premature infants. ( Hörnchen, H; Schefels, J; Skopnik, H; Wenzl, TG, 1998) |
| "A patient with myelofibrosis complicated by recurrent candidemia died despite treatment with amphotericin B and fluconazole." | 1.30 | Analysis by pulsed-field gel electrophoresis of Candida albicans that developed resistance during antifungal therapy. ( Matsumura, M; Mori, T; Oguri, T, 1998) |
| "parapsilosis in a cancer center within 10 years, with the aim to compare risk factors and the outcome with fungemias caused by C." | 1.30 | Candida parapsilosis fungemia in cancer patients--incidence, risk factors and outcome. ( Grausová, S; Krcméry, V; Krupová, I; Mardiak, J; Roidová, A; Sálek, T; Spánik, S; Sufliarsky, J; Trupl, J, 1998) |
| "Yeast fungemia has increased markedly in the last few years." | 1.30 | [A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)]. ( Cuenca-Estrella, M; Rodríguez-Tudela, JL, 1999) |
| "(NAC) in a single National Cancer Institution within 10 years were analysed for aetiology, risk factors and outcome." | 1.30 | Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution. ( Grey, E; Jurga, L; Krcmery, V; Kunova, A; Mardiak, J; Mateicka, F; Mrazova, M; Novotny, J; Sabo, A; Sevcikova, L; Sorkovska, D; Sufliarsky, J; Trupl, J; West, D, 1999) |
| "This syndrome has a favorable prognosis." | 1.29 | A radiologic syndrome after high dose chemotherapy and autologous bone marrow transplantation, with clinical and pathologic features of systemic candidiasis. ( Hussein, A; Meisenberg, B; Mudad, R; Paulson, EK; Peters, WP; Ross, M; Vredenburgh, J, 1994) |
| "Cryptococcal meningitis was diagnosed in a 71-year-old male diabetic patient with underlying ischaemic heart disease, asthma and bilateral axillo-femoral vascular grafts." | 1.29 | Pyrolysis typing of isolates from a recurrence of systemic cryptococcosis. ( Hosein, IK; Magee, JT; Philpot, C; Yang, J, 1994) |
| "Fungal endocarditis is considered an absolute indication for valve replacement surgery." | 1.29 | Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis. ( Hinthorn, DR; Klotz, SA; Zahid, MA, 1994) |
| "Fluconazole was reasonably well tolerated." | 1.29 | Treatment of Candida albicans fungaemia with fluconazole. ( Georgopoulos, A; Graninger, W; Presteril, E; Schneeweiss, B; Teleky, B, 1993) |
| "Fluconazole is considered to be a potent, safe antifungal agent for the treatment of suspected fungal infections associated with hematological diseases." | 1.29 | [Clinical efficacy of fluconazole against fungal infections in hematological diseases]. ( Asahara, F; Hisano, S; Kawasaki, C; Kimura, N; Morioka, E; Nagano, M; Nakashima, H; Okumura, M; Suzumiya, J; Uchida, T; Yoshida, T, 1996) |
| "Fluconazole was administered to these patients for a mean of 20 days at doses ranging from 100 to 200 mg/d." | 1.28 | Treatment of candidemia in critically ill surgical patients with intravenous fluconazole. ( León, C; Martín, E; Nolla-Salas, J; Sitges-Serra, A; Torres-Rodríguez, JM, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 104 (28.26) | 18.2507 |
| 2000's | 194 (52.72) | 29.6817 |
| 2010's | 57 (15.49) | 24.3611 |
| 2020's | 13 (3.53) | 2.80 |
| Authors | Studies |
|---|---|
| Pai, MP | 3 |
| Turpin, RS | 3 |
| Garey, KW | 4 |
| da Matta, VL | 1 |
| de Souza Carvalho Melhem, M | 1 |
| Colombo, AL | 4 |
| Moretti, ML | 1 |
| Rodero, L | 1 |
| Duboc de Almeida, GM | 1 |
| dos Anjos Martins, M | 1 |
| Costa, SF | 1 |
| Souza Dias, MB | 1 |
| Nucci, M | 3 |
| Levin, AS | 1 |
| Seifert, H | 1 |
| Aurbach, U | 2 |
| Stefanik, D | 1 |
| Cornely, O | 1 |
| Fritsche, TR | 1 |
| Rhomberg, PR | 1 |
| Sader, HS | 3 |
| Jones, RN | 7 |
| Gomez-Lopez, A | 1 |
| Alastruey-Izquierdo, A | 1 |
| Rodriguez, D | 2 |
| Almirante, B | 4 |
| Pahissa, A | 3 |
| Rodriguez-Tudela, JL | 7 |
| Cuenca-Estrella, M | 6 |
| Cleary, JD | 2 |
| Garcia-Effron, G | 2 |
| Chapman, SW | 3 |
| Perlin, DS | 3 |
| Kontoyiannis, DP | 7 |
| Lewis, RE | 2 |
| Chapeland-Leclerc, F | 1 |
| Hennequin, C | 4 |
| Papon, N | 1 |
| Noël, T | 1 |
| Girard, A | 1 |
| Socié, G | 2 |
| Ribaud, P | 2 |
| Lacroix, C | 2 |
| Bai, Y | 1 |
| Zheng, Z | 1 |
| Liu, T | 1 |
| Yan, Z | 1 |
| Du, M | 1 |
| Yao, H | 1 |
| Liu, Y | 1 |
| Suo, J | 1 |
| Mpakosi, A | 1 |
| Siopi, M | 1 |
| Demetriou, M | 1 |
| Falaina, V | 1 |
| Theodoraki, M | 1 |
| Meletiadis, J | 1 |
| Samaddar, A | 1 |
| Sharma, A | 1 |
| Yadav, A | 1 |
| Jain, P | 1 |
| Jain, K | 1 |
| Wang, Y | 2 |
| Singh, A | 2 |
| Xu, J | 2 |
| Chowdhary, A | 2 |
| Díaz-García, J | 2 |
| Mesquida, A | 2 |
| Machado, M | 1 |
| Sánchez-Carrillo, C | 2 |
| Muñoz, P | 5 |
| Escribano, P | 2 |
| Guinea, J | 3 |
| Sig, AK | 1 |
| Çetin-Duran, A | 1 |
| Kula-Atik, T | 1 |
| Kim, SE | 1 |
| Jung, SI | 1 |
| Park, KH | 1 |
| Choi, YJ | 1 |
| Won, EJ | 2 |
| Shin, JH | 2 |
| Murphy, LS | 1 |
| Lacy, AJ | 1 |
| Smith, AT | 1 |
| Shah, KS | 1 |
| Murata, Y | 1 |
| Okabe, S | 1 |
| Tamagawa, S | 1 |
| Ohnishi, H | 1 |
| Sakai, A | 1 |
| Itoh, K | 1 |
| Iwasaki, H | 1 |
| Negoro, E | 1 |
| Shigemi, H | 1 |
| Tokimatsu, I | 2 |
| Tsutani, H | 1 |
| Yamauchi, T | 1 |
| Reigadas, E | 1 |
| Hebert, J | 1 |
| Barr, E | 1 |
| Magee, C | 1 |
| Özdemir, ZC | 1 |
| Bozkurt Turhan, A | 1 |
| Düzenli Kar, Y | 1 |
| Dinleyici, ÇE | 1 |
| Bör, Ö | 1 |
| Oliveira, MME | 1 |
| Lemos, AS | 1 |
| Gonçalves, MLC | 1 |
| Almeida-Paes, R | 1 |
| Valviesse, VRGA | 1 |
| Moreira, JA | 1 |
| Lima, MASD | 1 |
| Carregal, E | 1 |
| Gutierrez Galhardo, MC | 1 |
| Lamas, CDC | 1 |
| Zancopé Oliveira, RM | 1 |
| Astvad, KMT | 1 |
| Johansen, HK | 1 |
| Røder, BL | 1 |
| Rosenvinge, FS | 1 |
| Knudsen, JD | 1 |
| Lemming, L | 1 |
| Schønheyder, HC | 1 |
| Hare, RK | 1 |
| Kristensen, L | 1 |
| Nielsen, L | 1 |
| Gertsen, JB | 1 |
| Dzajic, E | 1 |
| Pedersen, M | 1 |
| Østergård, C | 1 |
| Olesen, B | 1 |
| Søndergaard, TS | 1 |
| Arendrup, MC | 2 |
| Hsu, JF | 1 |
| Lai, MY | 1 |
| Lee, CW | 1 |
| Chu, SM | 1 |
| Wu, IH | 1 |
| Huang, HR | 1 |
| Lee, IT | 1 |
| Chiang, MC | 1 |
| Fu, RH | 1 |
| Tsai, MH | 1 |
| Chen, Y | 1 |
| Zhao, J | 1 |
| Han, L | 1 |
| Qi, L | 1 |
| Fan, W | 1 |
| Liu, J | 1 |
| Wang, Z | 1 |
| Xia, X | 1 |
| Chen, J | 1 |
| Zhang, L | 1 |
| Arastehfar, A | 1 |
| Bakhtiari, M | 1 |
| Daneshnia, F | 1 |
| Fang, W | 1 |
| Sadati, SK | 1 |
| Al-Hatmi, AM | 1 |
| Groenewald, M | 1 |
| Sharifi-Mehr, H | 1 |
| Liao, W | 1 |
| Pan, W | 1 |
| Zomorodian, K | 1 |
| Hagen, F | 2 |
| Boekhout, T | 2 |
| Chen, IT | 1 |
| Chen, CC | 1 |
| Huang, HC | 1 |
| Kuo, KC | 1 |
| Sasai, D | 1 |
| Okubo, Y | 1 |
| Ishiwatari, T | 1 |
| Sugita, T | 2 |
| Kaneko, T | 1 |
| Murayama, SY | 2 |
| Shimamura, T | 1 |
| Shinozaki, M | 1 |
| Hasegawa, C | 1 |
| Mitsuda, A | 1 |
| Tochigi, N | 1 |
| Wakayama, M | 1 |
| Nemoto, T | 1 |
| Shibuya, K | 1 |
| Trpković, A | 1 |
| Pekmezović, M | 1 |
| Barać, A | 1 |
| Crnčević Radović, L | 1 |
| Arsić Arsenijević, V | 1 |
| Ahmad, KM | 1 |
| Ishchuk, OP | 1 |
| Hellborg, L | 1 |
| Jørgensen, G | 1 |
| Skvarc, M | 1 |
| Stenderup, J | 1 |
| Jørck-Ramberg, D | 1 |
| Polakova, S | 1 |
| Piškur, J | 1 |
| Chioukh, FZ | 1 |
| Ben Hmida, H | 1 |
| Ben Ameur, K | 1 |
| Toumi, A | 1 |
| Monastiri, K | 1 |
| Bertz, H | 1 |
| Drognitz, K | 1 |
| Lübbert, M | 1 |
| Sharma, C | 1 |
| Duggal, S | 1 |
| Agarwal, K | 1 |
| Prakash, A | 1 |
| Singh, PK | 1 |
| Jain, S | 1 |
| Kathuria, S | 1 |
| Randhawa, HS | 1 |
| Meis, JF | 2 |
| Kubisiak-Rzepczyk, H | 1 |
| Gil, L | 1 |
| Zawirska, A | 1 |
| Kubisiak-Michalska, A | 1 |
| Mol, A | 1 |
| Reich, A | 1 |
| Komarnicki, M | 1 |
| Adamski, Z | 1 |
| Blennow, O | 1 |
| Ljungman, P | 1 |
| Sparrelid, E | 1 |
| Mattsson, J | 1 |
| Remberger, M | 1 |
| Ali, N | 1 |
| Adil, SN | 1 |
| Shaikh, MU | 1 |
| Lollis, TR | 1 |
| Bradshaw, WT | 1 |
| Leuck, AM | 1 |
| Rothenberger, MK | 1 |
| Green, JS | 1 |
| Takaoka, K | 1 |
| Nannya, Y | 1 |
| Shinohara, A | 1 |
| Arai, S | 1 |
| Nakamura, F | 1 |
| Kurokawa, M | 1 |
| Minea, B | 1 |
| Nastasa, V | 2 |
| Moraru, RF | 1 |
| Kolecka, A | 1 |
| Flonta, MM | 1 |
| Marincu, I | 1 |
| Man, A | 1 |
| Toma, F | 1 |
| Lupse, M | 1 |
| Doroftei, B | 2 |
| Marangoci, N | 1 |
| Pinteala, M | 1 |
| Mares, M | 2 |
| Langelier, C | 1 |
| Baxi, SM | 1 |
| Iribarne, D | 1 |
| Chin-Hong, P | 1 |
| Siddiqui, W | 1 |
| Ahmed, Y | 1 |
| Albrecht, H | 1 |
| Weissman, S | 1 |
| Shubitz, LF | 1 |
| Trinh, HT | 1 |
| Galgiani, JN | 1 |
| Lewis, ML | 1 |
| Fothergill, AW | 3 |
| Wiederhold, NP | 2 |
| Barker, BM | 1 |
| Lewis, ER | 1 |
| Doyle, AL | 1 |
| Hoekstra, WJ | 1 |
| Schotzinger, RJ | 1 |
| Garvey, EP | 1 |
| Chen, M | 1 |
| Wang, X | 1 |
| Yu, X | 1 |
| Dai, C | 1 |
| Chen, D | 1 |
| Yu, C | 1 |
| Xu, X | 1 |
| Yao, D | 1 |
| Yang, L | 1 |
| Li, Y | 1 |
| Wang, L | 1 |
| Huang, X | 1 |
| Dabas, Y | 1 |
| Bakhshi, S | 1 |
| Xess, I | 1 |
| Rachadi, H | 1 |
| Senouci, K | 1 |
| Lyagoubi, M | 1 |
| Benzekri, A | 1 |
| Mansouri, S | 1 |
| Ramli, I | 1 |
| Ismaili, N | 1 |
| Hassam, B | 1 |
| Benzekri, L | 1 |
| Choi, MJ | 1 |
| Kim, SH | 1 |
| Lee, WG | 1 |
| Kim, MN | 1 |
| Lee, K | 3 |
| Shin, MG | 1 |
| Suh, SP | 1 |
| Ryang, DW | 1 |
| Im, YJ | 1 |
| Karabıçak, N | 1 |
| Alem, N | 1 |
| Zhu, TH | 1 |
| Rodriguez, PG | 1 |
| Behan, JW | 1 |
| Declerck, B | 1 |
| Kim, GH | 1 |
| Martin, IW | 1 |
| Tonner, R | 1 |
| Trivedi, J | 1 |
| Miller, H | 1 |
| Lee, R | 1 |
| Liang, X | 1 |
| Rotello, L | 1 |
| Isenbergh, E | 1 |
| Anderson, J | 1 |
| Perl, T | 1 |
| Zhang, SX | 1 |
| Durán Graeff, L | 1 |
| Seidel, D | 1 |
| Vehreschild, MJ | 1 |
| Hamprecht, A | 1 |
| Kindo, A | 1 |
| Racil, Z | 1 |
| Demeter, J | 1 |
| De Hoog, S | 1 |
| Ziegler, M | 1 |
| Wisplinghoff, H | 1 |
| Cornely, OA | 1 |
| Baddley, JW | 3 |
| Patel, M | 2 |
| Bhavnani, SM | 1 |
| Moser, SA | 3 |
| Andes, DR | 1 |
| Schuster, MG | 1 |
| Edwards, JE | 5 |
| Sobel, JD | 3 |
| Darouiche, RO | 1 |
| Karchmer, AW | 3 |
| Hadley, S | 3 |
| Slotman, G | 1 |
| Panzer, H | 2 |
| Biswas, P | 1 |
| Rex, JH | 5 |
| Fekete, T | 1 |
| Kaufman, DA | 1 |
| Salemis, NS | 1 |
| Tsolakis, K | 1 |
| Aloizos, S | 1 |
| Tsohataridis, E | 1 |
| Saha, R | 1 |
| Das Das, S | 1 |
| Kumar, A | 1 |
| Kaur, IR | 1 |
| Kappe, R | 1 |
| Fuchs, E | 1 |
| Gorges, A | 1 |
| Rimek, D | 1 |
| Tumbarello, M | 3 |
| Sanguinetti, M | 2 |
| Trecarichi, EM | 2 |
| La Sorda, M | 1 |
| Rossi, M | 1 |
| de Carolis, E | 1 |
| de Gaetano Donati, K | 1 |
| Fadda, G | 1 |
| Cauda, R | 2 |
| Posteraro, B | 2 |
| Pasqualotto, AC | 1 |
| Zimerman, RA | 2 |
| Alves, SH | 1 |
| Aquino, VR | 2 |
| Branco, D | 1 |
| Wiltgen, D | 1 |
| do Amaral, A | 1 |
| Cechinel, R | 1 |
| Colares, SM | 1 |
| da Rocha, IG | 1 |
| Severo, LC | 1 |
| Sukiennik, TC | 1 |
| Vervaeke, S | 1 |
| Vandamme, K | 1 |
| Boone, E | 1 |
| De Laere, E | 1 |
| Swinne, D | 1 |
| Surmont, I | 1 |
| Labelle, AJ | 1 |
| Micek, ST | 1 |
| Roubinian, N | 1 |
| Kollef, MH | 3 |
| Peláez, T | 2 |
| Rodríguez-Créixems, M | 2 |
| Torres-Narbona, M | 1 |
| Alcalá, L | 2 |
| Bouza, E | 3 |
| Al-Sweih, N | 1 |
| Khan, Z | 1 |
| Khan, S | 2 |
| Devarajan, LV | 1 |
| Faiz, S | 1 |
| Neale, B | 1 |
| Rios, E | 1 |
| Campos, T | 1 |
| Parsley, E | 1 |
| Patel, B | 1 |
| Ostrosky-Zeichner, L | 2 |
| Lee, I | 2 |
| Fishman, NO | 2 |
| Zaoutis, TE | 2 |
| Morales, KH | 2 |
| Weiner, MG | 1 |
| Synnestvedt, M | 1 |
| Nachamkin, I | 2 |
| Lautenbach, E | 2 |
| Magill, SS | 3 |
| Swoboda, SM | 3 |
| Shields, CE | 1 |
| Colantuoni, EA | 1 |
| Merz, WG | 4 |
| Lipsett, PA | 2 |
| Hendrix, CW | 2 |
| Ruan, SY | 2 |
| Huang, YT | 1 |
| Chu, CC | 1 |
| Yu, CJ | 1 |
| Hsueh, PR | 4 |
| Klevay, MJ | 1 |
| Horn, DL | 2 |
| Neofytos, D | 3 |
| Pfaller, MA | 14 |
| Diekema, DJ | 7 |
| Yang, BH | 1 |
| Peng, MY | 1 |
| Hou, SJ | 1 |
| Sun, JR | 1 |
| Lee, SY | 1 |
| Lu, JJ | 1 |
| Anaissie, EJ | 3 |
| Fishman, JA | 1 |
| Steinbach, WJ | 1 |
| Olyaei, AJ | 1 |
| Marr, KA | 4 |
| Chang, CH | 1 |
| Webster, KM | 1 |
| Donnelly, JP | 2 |
| Lass-Flörl, C | 1 |
| Salavert-Lletí, M | 1 |
| Zaragoza-Crespo, R | 1 |
| Furman-Kuklińska, K | 1 |
| Naumnik, B | 1 |
| Myśliwiec, M | 1 |
| Chien, JY | 1 |
| Hou, YC | 1 |
| Zilberberg, MD | 1 |
| Kothari, S | 1 |
| Shorr, AF | 3 |
| Pemán, J | 2 |
| Borges Sá, M | 1 |
| Garnacho Montero, J | 1 |
| Tan, TY | 1 |
| Tan, AL | 1 |
| Tee, NW | 1 |
| Ng, LS | 1 |
| Chee, CW | 1 |
| Bassetti, M | 2 |
| Ansaldi, F | 1 |
| Nicolini, L | 1 |
| Malfatto, E | 1 |
| Molinari, MP | 2 |
| Mussap, M | 1 |
| Rebesco, B | 1 |
| Bobbio Pallavicini, F | 1 |
| Icardi, G | 1 |
| Viscoli, C | 2 |
| Choi, HK | 1 |
| Jeong, SJ | 1 |
| Lee, HS | 1 |
| Chin, BS | 1 |
| Choi, SH | 1 |
| Han, SH | 1 |
| Kim, MS | 1 |
| Kim, CO | 1 |
| Choi, JY | 1 |
| Song, YG | 1 |
| Kim, JM | 1 |
| Dannaoui, E | 1 |
| Paugam, A | 1 |
| Develoux, M | 1 |
| Chochillon, C | 1 |
| Matheron, J | 1 |
| Datry, A | 1 |
| Bouges-Michel, C | 2 |
| Bonnal, C | 1 |
| Dromer, F | 2 |
| Bretagne, S | 1 |
| Minces, LR | 1 |
| Ho, KS | 1 |
| Veldkamp, PJ | 1 |
| Clancy, CJ | 3 |
| Tilak, R | 1 |
| Prakash, P | 1 |
| Nigam, C | 1 |
| Tilak, V | 1 |
| Gambhir, IS | 1 |
| Gulati, AK | 1 |
| Cohen, Y | 2 |
| Karoubi, P | 1 |
| Adrie, C | 1 |
| Gauzit, R | 2 |
| Marsepoil, T | 1 |
| Zarka, D | 1 |
| Clec'h, C | 1 |
| Sun, HY | 1 |
| Alexander, BD | 2 |
| Lortholary, O | 2 |
| Forrest, GN | 2 |
| Lyon, GM | 1 |
| Somani, J | 1 |
| Gupta, KL | 1 |
| Del Busto, R | 1 |
| Pruett, TL | 1 |
| Sifri, CD | 1 |
| Limaye, AP | 1 |
| John, GT | 1 |
| Klintmalm, GB | 1 |
| Pursell, K | 1 |
| Stosor, V | 1 |
| Morris, MI | 1 |
| Dowdy, LA | 1 |
| Kalil, AC | 1 |
| Garcia-Diaz, J | 1 |
| Orloff, SL | 1 |
| House, AA | 1 |
| Houston, SH | 1 |
| Wray, D | 1 |
| Huprikar, S | 1 |
| Johnson, LB | 1 |
| Humar, A | 1 |
| Razonable, RR | 1 |
| Fisher, RA | 1 |
| Husain, S | 1 |
| Wagener, MM | 2 |
| Singh, N | 1 |
| Kludze-Forson, M | 1 |
| Eschenauer, GA | 2 |
| Kubin, CJ | 1 |
| Della-Latta, P | 1 |
| Lam, SW | 1 |
| Slavin, MA | 1 |
| Sorrell, TC | 2 |
| Marriott, D | 2 |
| Thursky, KA | 1 |
| Nguyen, Q | 1 |
| Ellis, DH | 1 |
| Morrissey, CO | 1 |
| Chen, SC | 1 |
| Hebert, C | 1 |
| Villaran, R | 1 |
| Tolentino, J | 2 |
| Best, L | 1 |
| Boonlayangoor, S | 1 |
| Pitrak, D | 1 |
| Lin, M | 1 |
| Weber, SG | 2 |
| Gabrielian, A | 1 |
| Hariprasad, SM | 1 |
| Playford, EG | 1 |
| Nimmo, GR | 1 |
| Tilse, M | 1 |
| Hager, JL | 1 |
| Mir, MR | 1 |
| Hsu, S | 1 |
| Oxman, DA | 1 |
| Chow, JK | 1 |
| Frendl, G | 1 |
| Hershkovitz, S | 1 |
| Ireland, P | 1 |
| McDermott, LA | 1 |
| Tsai, K | 1 |
| Marty, FM | 1 |
| Golan, Y | 1 |
| Garnacho-Montero, J | 1 |
| Díaz-Martín, A | 1 |
| García-Cabrera, E | 1 |
| Ruiz Pérez de Pipaón, M | 1 |
| Hernández-Caballero, C | 1 |
| Aznar-Martín, J | 1 |
| Cisneros, JM | 1 |
| Ortiz-Leyba, C | 1 |
| Mershon-Shier, KL | 1 |
| Deville, JG | 1 |
| Delair, S | 1 |
| Wickes, B | 1 |
| de Hoog, GS | 1 |
| Sutton, DA | 1 |
| Lewinski, MA | 1 |
| Verma, S | 1 |
| Bharti, B | 1 |
| Inusha, P | 1 |
| Cervera, C | 1 |
| Linares, L | 1 |
| Reverté, E | 1 |
| Escorsell, A | 1 |
| Moreno, A | 1 |
| Poikonen, E | 1 |
| Lyytikäinen, O | 2 |
| Anttila, VJ | 2 |
| Koivula, I | 1 |
| Lumio, J | 1 |
| Kotilainen, P | 1 |
| Syrjälä, H | 1 |
| Ruutu, P | 1 |
| Ito, M | 1 |
| Yokoi, T | 1 |
| Sugita, S | 1 |
| Shinohara, N | 1 |
| Nishina, S | 1 |
| Azuma, N | 1 |
| Ramona, FM | 1 |
| Stefanache, A | 1 |
| Kido, N | 1 |
| Makimura, K | 2 |
| Kamegaya, C | 1 |
| Shindo, I | 1 |
| Shibata, E | 1 |
| Omiya, T | 1 |
| Yamamoto, Y | 1 |
| Hamoud, S | 1 |
| Keidar, Z | 1 |
| Hayek, T | 1 |
| Nakase, K | 1 |
| Suzuki, K | 1 |
| Kyo, T | 3 |
| Kohara, T | 2 |
| Sugawara, Y | 1 |
| Katayama, N | 1 |
| Dierberg, KL | 1 |
| Subramanian, A | 1 |
| Nace, H | 1 |
| Desai, N | 1 |
| Locke, JE | 1 |
| Zhang, S | 1 |
| Diaz, J | 1 |
| Chamberlain, C | 1 |
| Westbrook, SD | 1 |
| Kirkpatrick, WR | 1 |
| Freytes, CO | 1 |
| Toro, JJ | 1 |
| Patterson, TF | 1 |
| Redding, SW | 1 |
| True, DG | 1 |
| Penmetcha, M | 1 |
| Peckham, SJ | 1 |
| Safdar, A | 2 |
| Chaturvedi, V | 1 |
| Koll, BS | 1 |
| Larone, DH | 1 |
| Armstrong, D | 1 |
| Garbino, J | 4 |
| Kolarova, L | 1 |
| Rohner, P | 2 |
| Lew, D | 2 |
| Pichna, P | 3 |
| Pittet, D | 2 |
| Fernández-Turégano, CP | 1 |
| Averbuch, D | 1 |
| Boekhoutt, T | 1 |
| Falk, R | 1 |
| Engelhard, D | 2 |
| Shapiro, M | 1 |
| Block, C | 1 |
| Polacheck, I | 1 |
| Candelli, M | 1 |
| Nista, EC | 1 |
| Nestola, M | 1 |
| Armuzzi, A | 1 |
| Silveri, NG | 1 |
| Gasbarrini, G | 1 |
| Gasbarrini, A | 1 |
| Alvarez-Lerma, F | 2 |
| Nolla, J | 1 |
| Palomar, M | 2 |
| León, MA | 1 |
| Dupont, H | 1 |
| Montravers, P | 1 |
| Timsit, JF | 1 |
| Veber, B | 1 |
| Chevalier, E | 1 |
| Blin, P | 1 |
| Palestro, B | 1 |
| Boyken, L | 3 |
| Messer, SA | 8 |
| Tendolkar, S | 2 |
| Hollis, RJ | 6 |
| Odds, FC | 2 |
| Pappas, PG | 5 |
| Sobel, J | 1 |
| Brass, C | 1 |
| Vazquez, JA | 2 |
| Horowitz, HW | 2 |
| Zervos, M | 1 |
| McKinsey, D | 1 |
| Lee, J | 2 |
| Babinchak, T | 1 |
| Bradsher, RW | 1 |
| Cohen, DM | 1 |
| Danziger, L | 1 |
| Goldman, M | 1 |
| Goodman, J | 1 |
| Hilton, E | 1 |
| Hyslop, NE | 1 |
| Kett, DH | 2 |
| Lutz, J | 1 |
| Rubin, RH | 1 |
| Scheld, WM | 2 |
| Schuster, M | 1 |
| Simmons, B | 1 |
| Stein, DK | 1 |
| Washburn, RG | 2 |
| Mautner, L | 1 |
| Chu, TC | 1 |
| Rosenstein, RB | 1 |
| Booth, J | 1 |
| Myoken, Y | 2 |
| Fujihara, M | 1 |
| Sugata, T | 2 |
| Mikami, Y | 2 |
| McGee, WT | 1 |
| Tereso, GJ | 1 |
| Gottfredsson, M | 1 |
| Vredenburgh, JJ | 1 |
| Schell, WA | 2 |
| Perfect, JR | 2 |
| Schnyder, I | 1 |
| Bouchuiguir-Wafa, K | 1 |
| Hamill, RJ | 1 |
| Larsen, RA | 1 |
| Powderly, W | 1 |
| Kauffman, CA | 1 |
| Hyslop, N | 1 |
| Mangino, JE | 1 |
| Chapman, S | 1 |
| Dismukes, WE | 2 |
| Gökahmetoglu, S | 1 |
| Nedret Koç, A | 2 |
| Patiroglu, T | 2 |
| Nakagawa, Z | 1 |
| Valdetaro, F | 1 |
| Branchini, ML | 1 |
| Kussano, EJ | 1 |
| Gudlaugsson, O | 1 |
| Gillespie, S | 1 |
| Vande Berg, J | 1 |
| Hu, J | 1 |
| Messer, S | 1 |
| Herwaldt, L | 1 |
| Pfaller, M | 1 |
| Diekema, D | 1 |
| Schelenz, S | 1 |
| Gransden, WR | 1 |
| Bliss, JM | 1 |
| Wellington, M | 1 |
| Gigliotti, F | 1 |
| Kaufman, D | 2 |
| Han, XY | 1 |
| Tarrand, JJ | 1 |
| Escudero, E | 1 |
| Marchetti, O | 1 |
| Bille, J | 2 |
| Fluckiger, U | 1 |
| Eggimann, P | 1 |
| Ruef, C | 1 |
| Calandra, T | 1 |
| Glauser, MP | 1 |
| Täuber, MG | 1 |
| Sridhar, H | 1 |
| Subramanyam, JR | 1 |
| Appaji, L | 1 |
| Shafiulla, M | 1 |
| Vijaykumar, BR | 1 |
| Cheng, MF | 1 |
| Yu, KW | 1 |
| Tang, RB | 1 |
| Fan, YH | 1 |
| Yang, YL | 1 |
| Hsieh, KS | 1 |
| Ho, M | 1 |
| Lo, HJ | 1 |
| Torres, HA | 1 |
| Rolston, KV | 1 |
| Lipsetta, PA | 1 |
| Takakura, S | 1 |
| Fujihara, N | 1 |
| Saito, T | 1 |
| Kudo, T | 1 |
| Iinuma, Y | 1 |
| Ichiyama, S | 1 |
| Bakir, M | 2 |
| Cerikcioğlu, N | 2 |
| Tirtir, A | 1 |
| Berrak, S | 1 |
| Ozek, E | 1 |
| Canpolat, C | 1 |
| León, C | 2 |
| Olaechea, P | 1 |
| Cerdá, E | 1 |
| Bermejo, B | 1 |
| Molina, L | 1 |
| Hernando, S | 1 |
| del Palacio, A | 2 |
| Brown, JM | 1 |
| Wingard, JR | 2 |
| Wang, JL | 1 |
| Chang, SC | 1 |
| Chen, YC | 1 |
| Singh-Parikshak, R | 1 |
| Bothun, ED | 1 |
| Superstein, R | 1 |
| Del Monte, M | 1 |
| Archer, S | 1 |
| Johnson, MW | 1 |
| Jones, M | 1 |
| Cloud, G | 1 |
| Smith, AC | 1 |
| Jantunen, E | 1 |
| Nihtinen, A | 1 |
| Volin, L | 1 |
| Juvonen, E | 1 |
| Parkkali, T | 1 |
| Ruutu, T | 1 |
| Mondal, RK | 1 |
| Singhi, SC | 1 |
| Chakrabarti, A | 2 |
| M, J | 1 |
| Piarroux, R | 1 |
| Grenouillet, F | 1 |
| Balvay, P | 1 |
| Tran, V | 1 |
| Blasco, G | 1 |
| Millon, L | 1 |
| Boillot, A | 1 |
| Kamai, Y | 1 |
| Kakuta, M | 1 |
| Shibayama, T | 1 |
| Fukuoka, T | 1 |
| Kuwahara, S | 1 |
| Wang, CY | 1 |
| Jerng, JS | 1 |
| Ko, JC | 1 |
| Lin, MF | 1 |
| Hsiao, CH | 1 |
| Lee, LN | 1 |
| Kuo, SH | 1 |
| Tan, GL | 1 |
| Peterson, EM | 1 |
| Park, BJ | 1 |
| Planes, AM | 1 |
| Almela, M | 1 |
| Mensa, J | 1 |
| Sanchez, F | 1 |
| Ayats, J | 1 |
| Gimenez, M | 1 |
| Saballs, P | 1 |
| Fridkin, SK | 2 |
| Morgan, J | 1 |
| Warnock, DW | 2 |
| Sarvikivi, E | 1 |
| Soll, DR | 2 |
| Pujol, C | 2 |
| Richardson, M | 1 |
| Koukila-Kähkölä, P | 1 |
| Luukkainen, P | 1 |
| Saxén, H | 1 |
| Yu, VL | 2 |
| Morris, AJ | 2 |
| Snydman, DR | 2 |
| Nguyen, MH | 3 |
| Chung, K | 1 |
| Jackson, WL | 2 |
| Waterman, PE | 1 |
| Samra, Z | 1 |
| Yardeni, M | 1 |
| Peled, N | 1 |
| Bishara, J | 1 |
| Girmenia, C | 5 |
| Moleti, ML | 1 |
| Micozzi, A | 1 |
| Iori, AP | 1 |
| Barberi, W | 1 |
| Foà, R | 1 |
| Martino, P | 5 |
| Miller, JL | 1 |
| Long, GD | 1 |
| Luzzati, R | 1 |
| Allegranzi, B | 1 |
| Antozzi, L | 1 |
| Masala, L | 1 |
| Pegoraro, E | 1 |
| Azzini, A | 1 |
| Concia, E | 1 |
| Natarajan, G | 1 |
| Lulic-Botica, M | 1 |
| Rongkavilit, C | 1 |
| Pappas, A | 1 |
| Bedard, M | 1 |
| Angel-Moreno, A | 1 |
| Boronat, M | 1 |
| Bolaños, M | 1 |
| Carrillo, A | 1 |
| González, S | 1 |
| Pérez Arellano, JL | 1 |
| Lin, MY | 1 |
| Carmeli, Y | 1 |
| Zumsteg, J | 1 |
| Flores, EL | 1 |
| Sreeramoju, P | 1 |
| Minette, MS | 1 |
| Ibsen, LM | 1 |
| Giusiano, G | 2 |
| Mangiaterra, M | 2 |
| Saito, VG | 1 |
| Rojas, F | 2 |
| Gómez, V | 2 |
| Díaz, MC | 2 |
| Dutta, S | 1 |
| Murki, S | 1 |
| Varma, S | 1 |
| Narang, A | 1 |
| Shields, C | 1 |
| Sears, CL | 1 |
| Choti, M | 1 |
| Righi, E | 1 |
| Costa, A | 1 |
| Fasce, R | 1 |
| Rosso, R | 1 |
| Pallavicini, FB | 1 |
| Chong, PP | 1 |
| Chieng, DC | 1 |
| Low, LY | 1 |
| Hafeez, A | 1 |
| Shamsudin, MN | 1 |
| Seow, HF | 1 |
| Ng, KP | 2 |
| Cheng, YR | 1 |
| Lin, LC | 1 |
| Young, TG | 1 |
| Liu, CE | 1 |
| Chen, CH | 1 |
| Tsay, RW | 1 |
| Karabay, O | 1 |
| Madariaga, MG | 1 |
| Kocoglu, E | 1 |
| Ince, N | 1 |
| Kandirali, E | 1 |
| Edwards, JR | 1 |
| Shetty, S | 1 |
| Horan, T | 1 |
| Sendid, B | 1 |
| Cotteau, A | 1 |
| François, N | 1 |
| D'Haveloose, A | 1 |
| Standaert, A | 1 |
| Camus, D | 1 |
| Poulain, D | 1 |
| Panackal, AA | 1 |
| Gribskov, JL | 1 |
| Staab, JF | 1 |
| Kirby, KA | 1 |
| Rinaldi, M | 1 |
| Neuhauser, MM | 1 |
| Bearden, DT | 3 |
| Cannon, JP | 1 |
| Gentry, LO | 2 |
| Johnson, EA | 1 |
| Pelz, RK | 1 |
| Kofteridis, D | 1 |
| Mantadakis, E | 1 |
| Christidou, A | 1 |
| Samonis, G | 1 |
| Tascini, C | 1 |
| Ferranti, S | 1 |
| Leonildi, A | 1 |
| Menichetti, F | 1 |
| Blot, S | 1 |
| Janssens, R | 1 |
| Claeys, G | 1 |
| Hoste, E | 1 |
| Buyle, F | 1 |
| De Waele, JJ | 1 |
| Peleman, R | 1 |
| Vogelaers, D | 1 |
| Vandewoude, K | 1 |
| Sandven, P | 1 |
| Bevanger, L | 1 |
| Digranes, A | 1 |
| Haukland, HH | 1 |
| Mannsåker, T | 1 |
| Gaustad, P | 2 |
| Rege, M | 1 |
| Mingo, DE | 2 |
| Suda, KJ | 2 |
| Takashima, M | 1 |
| Poonwan, N | 1 |
| Mekha, N | 1 |
| Nakamura, T | 1 |
| Takahashi, H | 1 |
| Arcaya, NM | 1 |
| Mesa, LM | 1 |
| Pineda, MR | 1 |
| Beltrán-Luengo, H | 1 |
| Milagros Calvo, B | 1 |
| Garcia Saito, V | 1 |
| Lunardi, LW | 1 |
| Goldani, LZ | 1 |
| Barton, R | 1 |
| Yagci, A | 1 |
| Staley, B | 1 |
| Kennedy, HF | 1 |
| Shankland, GS | 1 |
| Bagg, J | 1 |
| Chalmers, EA | 1 |
| Gibson, BE | 1 |
| Williams, CL | 1 |
| Aoufi, S | 1 |
| Agoumi, A | 1 |
| Kushima, H | 1 |
| Hashinaga, K | 1 |
| Umeki, K | 1 |
| Ohama, M | 1 |
| Ishii, H | 1 |
| Kishi, K | 1 |
| Hiramatsu, K | 1 |
| Kadota, J | 1 |
| Garcia-Vidal, C | 1 |
| Carratalà, J | 1 |
| Ghannoum, MA | 1 |
| Kim, HG | 1 |
| Long, L | 1 |
| Rege, MD | 1 |
| Lazarus, DR | 1 |
| Sherner, JH | 1 |
| Morrel, M | 1 |
| Fraser, VJ | 1 |
| Jackson, ST | 1 |
| Smikle, MF | 1 |
| Antoine, MG | 1 |
| Roberts, GD | 1 |
| Pazos, C | 1 |
| Moragues, MD | 1 |
| Quindós, G | 2 |
| Pontón, J | 1 |
| Collins, CD | 1 |
| Salo, SL | 1 |
| Newton, DW | 1 |
| Khan, ZU | 1 |
| Al-Sweih, NA | 1 |
| Ahmad, S | 1 |
| Al-Kazemi, N | 1 |
| Joseph, L | 1 |
| Chandy, R | 1 |
| McCrossan, BA | 1 |
| McHenry, E | 1 |
| O'Neill, F | 1 |
| Ong, G | 1 |
| Sweet, DG | 1 |
| Etienne, M | 1 |
| Caron, F | 1 |
| Reboli, AC | 1 |
| Rotstein, C | 3 |
| Kumar, D | 1 |
| Betts, R | 1 |
| Wible, M | 1 |
| Goldstein, BP | 1 |
| Schranz, J | 1 |
| Krause, DS | 1 |
| Walsh, TJ | 1 |
| Revankar, SG | 1 |
| Metwally, L | 1 |
| Hogg, G | 1 |
| Coyle, PV | 1 |
| Hay, RJ | 1 |
| Hedderwick, S | 1 |
| McCloskey, B | 1 |
| O'Neill, HJ | 1 |
| Ong, GM | 1 |
| Thompson, G | 1 |
| Webb, CH | 1 |
| McMullan, R | 1 |
| Pacini, D | 1 |
| Cerana, M | 1 |
| Beltrame, A | 1 |
| Di Biagio, A | 1 |
| De Maria, A | 1 |
| Hanson, MF | 1 |
| Davidson, AD | 1 |
| Jacobsen, MD | 1 |
| Wright, P | 1 |
| Whyte, JA | 1 |
| Gow, NAR | 1 |
| Jones, BL | 1 |
| Rodríguez-Pardo, D | 1 |
| Laguna, F | 3 |
| Mouton, JW | 2 |
| Fujita, S | 1 |
| Senda, Y | 1 |
| Okusi, T | 1 |
| Ota, Y | 1 |
| Takada, H | 1 |
| Yamada, K | 1 |
| Kawano, M | 1 |
| Chai, YA | 1 |
| Khoo, AL | 1 |
| Chan, FY | 1 |
| Chow, C | 1 |
| Kumarasinghe, G | 1 |
| Singh, K | 1 |
| Tambyah, PA | 1 |
| Demirbileki, M | 1 |
| Timurkaynak, F | 1 |
| Can, F | 1 |
| Azap, O | 1 |
| Arslan, H | 1 |
| Sivasangeetha, K | 1 |
| Harish, BN | 1 |
| Sujatha, S | 1 |
| Parija, SC | 1 |
| Dutta, TK | 1 |
| Sánchez-Vargas, LO | 1 |
| Villar-Vidal, M | 1 |
| Eraso, E | 1 |
| Alkorta, M | 1 |
| Hernández-Almaraz, JL | 1 |
| Manzoni, P | 1 |
| Monstert, M | 1 |
| Agriesti, G | 1 |
| Priolo, C | 1 |
| Galletto, P | 1 |
| Farina, D | 1 |
| Weekes, E | 1 |
| Johnson, JK | 1 |
| Gibbs, DL | 1 |
| Newell, VA | 1 |
| Colombo, A | 1 |
| Finquelievich, J | 1 |
| Barnes, R | 1 |
| Wadula, J | 1 |
| van Hal, SJ | 1 |
| Stark, D | 1 |
| Harkness, J | 1 |
| Nomura, S | 1 |
| Iishii, K | 1 |
| Inami, N | 1 |
| Kimura, E | 1 |
| Urase, F | 1 |
| Negroni, R | 1 |
| Maiolo, E | 1 |
| Arechavala, AI | 1 |
| Bianchi, MH | 1 |
| Santiso, G | 1 |
| Kabbara, N | 1 |
| Peffault de Latour, R | 1 |
| Ghannoum, M | 1 |
| Hachem, R | 3 |
| Hanna, H | 1 |
| Kontoyiannis, D | 1 |
| Jiang, Y | 1 |
| Raad, I | 4 |
| Mudad, R | 1 |
| Vredenburgh, J | 1 |
| Paulson, EK | 1 |
| Ross, M | 1 |
| Meisenberg, B | 1 |
| Hussein, A | 1 |
| Peters, WP | 1 |
| Krcmery, S | 1 |
| Masar, O | 1 |
| Krcmery, V | 14 |
| Kamitsuka, MD | 1 |
| Nugent, NA | 1 |
| Conrad, PD | 1 |
| Swanson, TN | 1 |
| Berenguer, J | 1 |
| Fernández-Baca, V | 1 |
| Sánchez, R | 1 |
| Roilides, E | 1 |
| Bibashi, E | 1 |
| Acritidou, E | 1 |
| Trahana, M | 1 |
| Gompakis, N | 1 |
| Karpouzas, JG | 1 |
| Koliouskas, D | 1 |
| Coppola, S | 1 |
| Angarano, G | 1 |
| Montagna, MT | 1 |
| Congedo, P | 1 |
| Monno, L | 1 |
| Bellisario, A | 1 |
| Pastore, G | 1 |
| Barry, AL | 1 |
| Nelson, PW | 1 |
| Webb, CD | 1 |
| Yamada, S | 1 |
| Maruoka, T | 1 |
| Nagai, K | 1 |
| Tsumura, N | 1 |
| Yamada, T | 1 |
| Sakata, Y | 1 |
| Tominaga, K | 1 |
| Motohiro, T | 1 |
| Kato, H | 1 |
| Martínez-Suárez, JV | 1 |
| Adrados, M | 1 |
| Enríquez, A | 1 |
| Labenne, M | 1 |
| Benkerrou, M | 1 |
| Hambourg, M | 1 |
| DiNubile, MJ | 1 |
| Cofsky, RD | 1 |
| Tang, CM | 1 |
| Howe, P | 1 |
| Crook, DW | 1 |
| Solomkin, JS | 1 |
| Bennett, JE | 1 |
| Sugar, AM | 1 |
| van der Horst, CM | 1 |
| Dine, AP | 1 |
| Meunier, F | 2 |
| Nelson, MR | 1 |
| Fisher, M | 1 |
| Cartledge, J | 1 |
| Rogers, T | 1 |
| Gazzard, BG | 1 |
| Presterl, E | 3 |
| Graninger, W | 3 |
| Powderly, WG | 1 |
| Cloud, GA | 1 |
| Saag, MS | 1 |
| Price, MF | 1 |
| LaRocco, MT | 1 |
| Magee, JT | 1 |
| Philpot, C | 1 |
| Yang, J | 1 |
| Hosein, IK | 1 |
| Sarmiento, R | 1 |
| Holubka, J | 1 |
| Khatib, R | 2 |
| Zahid, MA | 1 |
| Klotz, SA | 1 |
| Hinthorn, DR | 1 |
| Ishikawa, Y | 1 |
| Shimizu, T | 1 |
| Sakiyama, Y | 1 |
| Matsumoto, S | 1 |
| Hatae, Y | 1 |
| Takeda, T | 1 |
| Ishikawa, A | 1 |
| Takase, A | 1 |
| Wagatsuma, Y | 1 |
| Cancelas, JA | 1 |
| Lopez, J | 1 |
| Cabezudo, E | 2 |
| Navas, E | 1 |
| Garcia Laraña, J | 1 |
| Jimenez Mena, M | 1 |
| Diz, P | 1 |
| Perez de Oteyza, J | 1 |
| Villalon, L | 1 |
| Sanchez-Sousa, A | 1 |
| Flynn, PM | 1 |
| Marina, NM | 1 |
| Rivera, GK | 1 |
| Hughes, WT | 1 |
| Nomura, J | 1 |
| Ruskin, J | 1 |
| Nassoura, Z | 1 |
| Ivatury, RR | 1 |
| Simon, RJ | 1 |
| Jabbour, N | 1 |
| Stahl, WM | 1 |
| Ponnuvel, KM | 1 |
| Rama, CP | 1 |
| Menon, T | 1 |
| Barchiesi, F | 1 |
| Morbiducci, V | 1 |
| Ancarani, F | 1 |
| Arzeni, D | 1 |
| Scalise, G | 1 |
| Presteril, E | 1 |
| Schneeweiss, B | 1 |
| Teleky, B | 1 |
| Georgopoulos, A | 1 |
| Ammassari, A | 1 |
| Linzalone, A | 1 |
| Murri, R | 1 |
| Marasca, G | 1 |
| Morace, G | 2 |
| Antinori, A | 1 |
| Cassone, A | 1 |
| Graybill, JR | 2 |
| Bocanegra, R | 1 |
| Luther, M | 1 |
| Jahnson, L | 1 |
| Chryssanthou, E | 1 |
| Petrini, B | 1 |
| Vikerfors, T | 1 |
| Glasgow, BJ | 1 |
| Engstrom, RE | 1 |
| Holland, GN | 1 |
| Kreiger, AE | 1 |
| Wool, MG | 1 |
| Peacock, JE | 1 |
| Tanner, DC | 1 |
| Nguyen, ML | 1 |
| Rinaldi, MG | 1 |
| Uzun, O | 3 |
| Still, JM | 1 |
| Belcher, K | 1 |
| Law, EJ | 1 |
| Vartivarian, SE | 1 |
| Abi-Said, D | 3 |
| Pinczowski, H | 1 |
| Khoury, P | 1 |
| Papadakis, K | 1 |
| Gardner, A | 1 |
| Raad, II | 2 |
| Gilbreath, J | 1 |
| Bodey, GP | 4 |
| Morioka, E | 1 |
| Asahara, F | 1 |
| Nagano, M | 1 |
| Kawasaki, C | 1 |
| Yoshida, T | 1 |
| Uchida, T | 1 |
| Nakashima, H | 1 |
| Suzumiya, J | 1 |
| Kimura, N | 1 |
| Hisano, S | 1 |
| Okumura, M | 1 |
| Bourée, P | 1 |
| Hiesse, C | 1 |
| Dupont, B | 1 |
| Charpentier, B | 1 |
| Bevilacqua, N | 1 |
| Federico, G | 1 |
| Tacconelli, E | 1 |
| Barnes, AJ | 1 |
| Wardley, AM | 1 |
| Oppenheim, BA | 1 |
| Morgenstern, GR | 1 |
| Scarffe, JH | 1 |
| Johnson, EM | 1 |
| Kelly, SL | 1 |
| Lamb, DC | 1 |
| Kelly, DE | 1 |
| Loeffler, J | 1 |
| Einsele, H | 2 |
| Driessen, M | 2 |
| Ellis, JB | 2 |
| Cooper, PA | 1 |
| Wainer, S | 1 |
| Muwazi, F | 2 |
| Hahn, D | 1 |
| Gous, H | 1 |
| De Villiers, FP | 2 |
| Nolte, FS | 1 |
| Parkinson, T | 1 |
| Falconer, DJ | 1 |
| Dix, S | 1 |
| Williams, J | 1 |
| Gilmore, C | 1 |
| Geller, R | 1 |
| Bregenzer, T | 1 |
| Evison-Eckstein, AC | 1 |
| Frei, R | 1 |
| Zimmerli, W | 1 |
| Voss, A | 2 |
| Kluytmans, JA | 1 |
| Koeleman, JG | 1 |
| Spanjaard, L | 1 |
| Vandenbroucke-Grauls, CM | 1 |
| Verbrugh, HA | 2 |
| Vos, MC | 1 |
| Weersink, AY | 1 |
| Hoogkamp-Korstanje, JA | 1 |
| Nolla-Salas, J | 2 |
| Sitges-Serra, A | 2 |
| León-Gil, C | 1 |
| Martínez-González, J | 1 |
| León-Regidor, MA | 1 |
| Ibáñez-Lucía, P | 1 |
| Torres-Rodríguez, JM | 2 |
| al Soub, H | 1 |
| Estinoso, W | 1 |
| López-Jiménez, J | 1 |
| Duarte-Palomino, R | 1 |
| Velasco-Martínez, JJ | 1 |
| Sousa, A | 1 |
| Odriozola, J | 1 |
| Hebart, H | 1 |
| Roller, G | 1 |
| Löffler, J | 1 |
| Rothenhofer, I | 1 |
| Müller, CA | 1 |
| Bowden, RA | 2 |
| van Burik, J | 1 |
| Kanz, L | 1 |
| Schumacher, U | 1 |
| Anaissie, E | 1 |
| Pinzcowski, H | 1 |
| Vartivarian, S | 1 |
| Phillips, P | 2 |
| Shafran, S | 2 |
| Garber, G | 2 |
| Smaill, F | 2 |
| Fong, I | 1 |
| Salit, I | 2 |
| Miller, M | 2 |
| Williams, K | 2 |
| Conly, JM | 1 |
| Singer, J | 2 |
| Ioannou, S | 2 |
| Manabe, A | 1 |
| Ebihara, Y | 1 |
| Saito, A | 1 |
| Takahashi, K | 1 |
| Hosoya, R | 1 |
| Scherer, WJ | 1 |
| Carrega, G | 1 |
| Riccio, G | 1 |
| Santoriello, L | 1 |
| Pasqualini, M | 1 |
| Pellicci, R | 1 |
| Alessandrini, F | 1 |
| Allegrini, F | 1 |
| Baldari, U | 1 |
| Cancellieri, C | 1 |
| Trupl, J | 7 |
| Kunová, A | 6 |
| Oravcová, E | 2 |
| Kukucková, E | 2 |
| Grausova, S | 4 |
| Grey, E | 3 |
| Spanik, S | 4 |
| Demitrovicová, A | 2 |
| Kralóvicová, K | 2 |
| Lacka, J | 1 |
| Krupova, I | 5 |
| Svec, J | 1 |
| Koren, P | 1 |
| Faucher, JF | 1 |
| Thiébaut, MM | 1 |
| Reynes, J | 1 |
| Janbon, F | 1 |
| Muñoz García de Paredes, P | 1 |
| Cobo Reinoso, P | 1 |
| Aguado García, JM | 1 |
| Lumbreras Bermejo, C | 1 |
| Pérez Vela, JL | 1 |
| Caballero Cubedo, R | 1 |
| Sanz Sanz, F | 1 |
| Noriega Rodríguez, AR | 1 |
| Mrazova-Studena, M | 1 |
| Stopkova-Grey, K | 1 |
| Inoue, Y | 1 |
| Yozu, R | 1 |
| Ueda, T | 1 |
| Kawada, S | 1 |
| Launay, O | 1 |
| Jarrousse, B | 1 |
| Bentata, M | 1 |
| Guillevin, L | 1 |
| Edmond, MB | 2 |
| Wenzel, RP | 2 |
| Lockhart, SR | 1 |
| Swails-Wenger, JA | 1 |
| Doern, GV | 2 |
| Kaiserova, E | 1 |
| Foltinova, A | 1 |
| Kovacicova, G | 5 |
| Kiskova, M | 1 |
| Krchnakova, A | 1 |
| West, D | 2 |
| Wenzl, TG | 1 |
| Schefels, J | 1 |
| Hörnchen, H | 1 |
| Skopnik, H | 1 |
| Mori, T | 1 |
| Matsumura, M | 1 |
| Oguri, T | 1 |
| Huttova, M | 3 |
| Hartmanova, I | 1 |
| Kralinsky, K | 2 |
| Filka, J | 1 |
| Uher, J | 1 |
| Kurak, J | 1 |
| Krizan, S | 1 |
| Roidová, A | 2 |
| Sálek, T | 1 |
| Sufliarsky, J | 2 |
| Mardiak, J | 2 |
| Mateicka, F | 6 |
| Hanzen, J | 5 |
| Clark, MA | 1 |
| Gaunt, T | 1 |
| Czachor, JS | 1 |
| Dranitsaris, G | 1 |
| Puodziunas, A | 1 |
| Conly, J | 1 |
| Brandt, ME | 1 |
| Hajjeh, RA | 1 |
| Pichnova, E | 1 |
| Sabo, A | 4 |
| Hoban, DJ | 1 |
| Zhanel, GG | 1 |
| Karlowsky, JA | 1 |
| de Pauw, BE | 1 |
| Pavese, P | 1 |
| Brion, JP | 1 |
| Lebeau, B | 1 |
| Grillot, R | 1 |
| Ambroise-Thomas, P | 1 |
| Robinson, LG | 1 |
| Jain, L | 1 |
| Kourtis, AP | 1 |
| Lassnigg, A | 1 |
| Mueller-Uri, P | 1 |
| El-Menyawi, I | 1 |
| Mrazova, M | 2 |
| Jurga, L | 3 |
| Sevcikova, L | 1 |
| Sorkovska, D | 1 |
| Novotny, J | 1 |
| Jandourek, A | 1 |
| Brown, P | 1 |
| Seidel, K | 1 |
| White, TC | 1 |
| Mizutani, S | 1 |
| Endo, M | 1 |
| Ino-Ue, T | 1 |
| Kurasawa, M | 1 |
| Uno, Y | 1 |
| Saito, H | 1 |
| Kato, I | 1 |
| Takesako, K | 1 |
| Thomas, F | 1 |
| Mebtouche, B | 1 |
| Clavier, H | 1 |
| Kalfon, P | 1 |
| Jarque, I | 1 |
| Saavedra, S | 1 |
| Martin, G | 1 |
| Pérez Bellés, C | 1 |
| Sanz, MA | 1 |
| Cawley, MJ | 1 |
| Braxton, GR | 1 |
| Haith, LR | 1 |
| Reilly, KJ | 1 |
| Guilday, RE | 1 |
| Patton, ML | 1 |
| Godwin, TA | 1 |
| Abbas, J | 2 |
| Hanna, HA | 2 |
| Mardani, M | 2 |
| Girgawy, E | 2 |
| Whimbey, E | 1 |
| Trenschel, R | 1 |
| Peceny, R | 1 |
| Runde, V | 1 |
| Elmaagacli, A | 1 |
| Dermoumi, H | 1 |
| Heintschel von Heinegg, E | 1 |
| Müller, KD | 1 |
| Schaefer, UW | 1 |
| Beelen, DW | 1 |
| Huang, YC | 1 |
| Lin, TY | 1 |
| Lien, RI | 1 |
| Chou, YH | 1 |
| Kuo, CY | 1 |
| Yang, PH | 1 |
| Hsieh, WS | 1 |
| Minari, A | 1 |
| Wong-Beringera, A | 1 |
| Hindler, J | 1 |
| Brankovic, L | 1 |
| Muehlbauer, L | 1 |
| Steele-Moore, L | 1 |
| Baran, J | 1 |
| Muckatira, B | 1 |
| Buijk, SL | 1 |
| Gyssens, IC | 1 |
| Touw, DJ | 1 |
| Bruining, HA | 1 |
| Smith, AM | 1 |
| Sulcová, M | 1 |
| Herbrecht, R | 1 |
| Zamfir, A | 1 |
| Letscher-Bru, V | 1 |
| Pisarcikova, M | 2 |
| Sejnova, D | 1 |
| Horn, J | 1 |
| Babela, R | 1 |
| Svetlansky, I | 1 |
| Lovaszova, M | 2 |
| Gogova, M | 1 |
| Wenisch, C | 1 |
| Moore, CB | 1 |
| Krause, R | 1 |
| Denning, DW | 1 |
| Díaz-Guerra, TM | 1 |
| Mellado, E | 1 |
| Mantzoros, CS | 1 |
| Paz, A | 1 |
| Gonen, R | 1 |
| Potasman, I | 1 |
| Fluit, AC | 1 |
| Caksen, H | 1 |
| Kurtoglu, S | 1 |
| Oztürk, A | 1 |
| Cetin, N | 1 |
| Ciftçi, A | 1 |
| Pagano, L | 1 |
| Leone, G | 1 |
| Laho, L | 1 |
| Ondrusova, A | 1 |
| Tarekova, Z | 1 |
| Liskova, A | 3 |
| Chovancova, D | 1 |
| Szovenyiova, Z | 2 |
| McKelvie, PA | 1 |
| Wong, EY | 1 |
| Chow, LP | 1 |
| Hall, AJ | 1 |
| Szovényová, Z | 1 |
| Chmelík, B | 1 |
| Ramos, L | 1 |
| López, C | 1 |
| Gómez, C | 1 |
| Mathurín, S | 1 |
| Mateo, A | 1 |
| van Rhee, F | 1 |
| Henslee-Downey, JP | 1 |
| Singhal, S | 1 |
| Mehta, J | 1 |
| Boyle, BM | 1 |
| Sullivan, DJ | 1 |
| Forkin, C | 1 |
| Mulcahy, F | 1 |
| Keane, CT | 1 |
| Coleman, DC | 1 |
| Krupova, Y | 1 |
| Milosovic, P | 1 |
| Lamosova, M | 1 |
| Macekova, L | 1 |
| Purgelova, A | 1 |
| Obertik, T | 1 |
| Hope, W | 1 |
| Morton, A | 1 |
| Eisen, DP | 1 |
| Boktour, M | 1 |
| Hachem, RY | 1 |
| Kaltenbach, G | 1 |
| Vogel, T | 1 |
| Noblet-Dick, M | 1 |
| Heitz, D | 1 |
| Berthel, M | 1 |
| Kuntzmann, F | 1 |
| Bukharie, HA | 1 |
| Erdem, F | 1 |
| Hirasaki, S | 1 |
| Ijichi, T | 1 |
| Fujita, N | 1 |
| Araki, S | 1 |
| Gotoh, H | 1 |
| Nakagawa, M | 1 |
| Siegman-Igra, Y | 1 |
| Rabaw, MY | 1 |
| Blumberg, HM | 1 |
| Hendershot, EF | 1 |
| Lott, TJ | 1 |
| Milatovic, D | 1 |
| Harms, K | 1 |
| Herting, E | 1 |
| Schiffmann, JH | 1 |
| Speer, CP | 1 |
| Abrahamsen, TG | 1 |
| Widing, E | 1 |
| Glomstein, A | 1 |
| Filler, SG | 1 |
| Martín, E | 1 |
| Propst, T | 1 |
| Vogel, W | 1 |
| Propst, A | 1 |
| Dietze, O | 1 |
| Braunsteiner, H | 1 |
| Santeiro, ML | 1 |
| Riggs, D | 1 |
| Weibley, RE | 1 |
| Bignardi, GE | 1 |
| Savage, MA | 1 |
| Coker, R | 1 |
| Davis, SG | 1 |
| Persons, DA | 1 |
| Laughlin, M | 1 |
| Tanner, D | 1 |
| Perfect, J | 1 |
| Gockerman, JP | 1 |
| Hathorn, JW | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical-microbiological Study of Oral Health Condition and Quality of Life of Children/Adolescent With Acute Lymphoid Leukemia and Acute Myeloid[NCT04968860] | 3 participants (Anticipated) | Observational [Patient Registry] | 2019-09-01 | Recruiting | |||
| ANTIVORIFUNGOL:Strategy of Antifungal Use in Oncohematological Neutropenic Patients. Use of Voriconazole as Early Treatment.[NCT00386802] | Phase 4 | 115 participants (Anticipated) | Interventional | 2006-08-31 | Completed | ||
| Candida in the Respiratory Tract Secretions of Critically Ill Patients and The Efficacy of Antifungal Treatment (The CANTREAT Study): A Prospective, Randomized, Double Blind, Placebo Controlled Pilot Study[NCT00934934] | Phase 2 | 61 participants (Actual) | Interventional | 2010-04-30 | Terminated (stopped due to slow enrollment) | ||
| A Phase III, Double-Blind, Randomized, Multi-Center, Study of the Safety and Efficacy of Anidulafungin vs. Fluconazole in the Treatment of Patients With Candidemia and Other Forms of Invasive Candidiasis and Prevention of Complications.[NCT00056368] | Phase 3 | 256 participants (Actual) | Interventional | 2003-03-31 | Completed | ||
| Anidulafungin in Patients With Hematologic Malignancies - An Open-label, Prospective Study to Evaluate the Safety Profile at Prophylactic and Therapeutic Dosages[NCT01053884] | Phase 2 | 10 participants (Actual) | Interventional | 2009-10-31 | Terminated (stopped due to reduced recruitment rate due to non infectious, but competitive trials at our institution) | ||
| Multi-center Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis[NCT00000708] | 120 participants | Interventional | Completed | ||||
| Comparison of Fluconazole (UK-49,858) and Amphotericin B for Maintenance Treatment of Cryptococcal Meningitis in Patients With Acquired Immunodeficiency Syndrome[NCT00001017] | Phase 3 | 330 participants | Interventional | Completed | |||
| Open Label, Limited Access Protocol of Posaconazole in Invasive Fungal Infections[NCT00033982] | Phase 3 | 50 participants | Interventional | 2002-04-11 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Sequential organ failure assessment. 0-24 The higher the number the more severe organ failure (NCT00934934)
Timeframe: post randomization
| Intervention | score on a scale (Mean) |
|---|---|
| Placebo | 5.9 |
| Antifungal | 5.9 |
Number of days free of antibiotic use within the first 28 days (NCT00934934)
Timeframe: 28 days
| Intervention | days (Median) |
|---|---|
| Placebo | 16 |
| Antifungal | 10 |
(NCT00934934)
Timeframe: 28 days
| Intervention | pg/ml (Mean) |
|---|---|
| VAP withCandida | 116 |
| VAP Without Candida | 129.1 |
(NCT00934934)
Timeframe: 28 days
| Intervention | mg/l (Mean) |
|---|---|
| VAP withCandida | 133 |
| VAP Without Candida | 145.7 |
Measure of the duration of participant stay in the ICU (NCT00934934)
Timeframe: 28 days
| Intervention | days (Median) |
|---|---|
| Placebo | 11.5 |
| Antifungal | 13 |
Measure of the duration of the participant's hospital stay (NCT00934934)
Timeframe: 90 days
| Intervention | days (Median) |
|---|---|
| Placebo | 29 |
| Antifungal | 28 |
Number of days free of ICU (NCT00934934)
Timeframe: 28 days
| Intervention | days (Median) |
|---|---|
| Placebo | 14 |
| Antifungal | 4 |
(NCT00934934)
Timeframe: 28 days
| Intervention | pg/ml (Mean) |
|---|---|
| VAP withCandida | 97.5 |
| VAP Without Candida | 3 |
Overall recruitment rate per site (NCT00934934)
Timeframe: 32 months
| Intervention | participants per site /month (Number) |
|---|---|
| Overall | 0.6 |
(NCT00934934)
Timeframe: 28 days
| Intervention | ng/ml (Mean) |
|---|---|
| VAP withCandida | 3.0 |
| VAP Without Candida | 22.5 |
Number of days in ICU free of ventilation (NCT00934934)
Timeframe: 28 days
| Intervention | days (Median) |
|---|---|
| Placebo | 8 |
| Antifungal | 9 |
39 reviews available for fluconazole and Fungemia
| Article | Year |
|---|---|
A fatal neonatal case of fungemia due to Exophiala dermatitidis-case report and literature review.
Topics: Anti-Bacterial Agents; Antifungal Agents; Exophiala; Fluconazole; Fungemia; Humans; Infant, Newborn; | 2022 |
Fungal prophylaxis in neonates: a review article.
Topics: Administration, Intravenous; Administration, Oral; Amphotericin B; Antifungal Agents; Aspergillosis; | 2014 |
Pseudozyma spp catheter-associated blood stream infection, an emerging pathogen and brief literature review.
Topics: Amphotericin B; Antifungal Agents; Catheter-Related Infections; Catheterization, Central Venous; Cen | 2014 |
Pleural effusion as the initial clinical presentation in disseminated cryptococcosis and fungaemia: an unusual manifestation and a literature review.
Topics: Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus neoformans; Fluconazole; Flucytosine | 2015 |
Fatal Cases of Bloodstream Infection by Fusarium solani and Review of Published Literature.
Topics: Adolescent; Aged; Amphotericin B; Antifungal Agents; Base Sequence; DNA, Intergenic; Fluconazole; Fu | 2016 |
Fluconazole-resistant Kodamaea ohmeri fungemia associated with cellulitis: case report and review of the literature.
Topics: Aged; Antifungal Agents; Cellulitis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Male; M | 2009 |
[Future role of micafungin in the treatment of invasive mycoses caused by filamentous fungi].
Topics: Adult; Animals; Antifungal Agents; Aspergillosis; Candidiasis; Child; Clinical Trials as Topic; Doub | 2009 |
[Current treatment of candidemia. Role of anidulafungin].
Topics: Adult; Aged; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Disease Suscep | 2008 |
[Role of anidulafungin in critically ill patients].
Topics: Amphotericin B; Anidulafungin; Antifungal Agents; Candidiasis; Clinical Trials as Topic; Critical Il | 2008 |
Fungemia in a cancer patient caused by fluconazole-resistant Cryptococcus laurentii.
Topics: Adolescent; Antifungal Agents; Cryptococcosis; Cryptococcus; Drug Resistance, Fungal; Fluconazole; F | 2002 |
An unusual cause of vertebral osteomyelitis: Candida species.
Topics: Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Discitis; Female; Fluconazole; Follow | 2003 |
Antifungal pharmacotherapy for neonatal candidiasis.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Cross Infection; Echinocandins; Flucona | 2003 |
Strategies for prevention of neonatal invasive candidiasis.
Topics: Antifungal Agents; Candidiasis; Chemoprevention; Cross Infection; Fluconazole; Fungemia; Humans; Inf | 2003 |
Infections by the yeast Kodomaea (Pichia) ohmeri: two cases and literature review.
Topics: Adolescent; Aged; Antifungal Agents; Disease Progression; Fatal Outcome; Fluconazole; Follow-Up Stud | 2004 |
Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.
Topics: Antifungal Agents; Candida; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests | 2004 |
Fusarium solani fungemia in a patient with acute lymphoblastic leukemia.
Topics: Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Fluconazole; Fungemia; Fus | 2001 |
Fungal infections in bone marrow transplant patients.
Topics: Antifungal Agents; Bone Marrow Transplantation; Fluconazole; Fungemia; Humans; Immunocompromised Hos | 2004 |
Empirical antifungal therapy in treating febrile neutropenic patients.
Topics: Amphotericin B; Antifungal Agents; Clinical Trials as Topic; Deoxycholic Acid; Drug Combinations; Fe | 2004 |
Fluconazole prophylaxis in critically ill surgical patients: a meta-analysis.
Topics: Antifungal Agents; Candidiasis; Critical Illness; Double-Blind Method; Drug Resistance, Fungal; Drug | 2005 |
Candida glabrata fungemia cured by antibiotic-lock therapy: case report and short review.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida glabrata; Candidiasis; Catheterization, Central Ve | 2005 |
[Management of fungal urinary tract infections].
Topics: Aged; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Cystitis; D | 2007 |
Neonatal fungal infections: the state of the art.
Topics: Antifungal Agents; Birth Weight; Candidiasis; Clinical Trials as Topic; Fluconazole; Fungemia; Gesta | 2007 |
Acremonium fungemia in two immunocompromised children.
Topics: Acremonium; Amphotericin B; Catheterization, Central Venous; Child, Preschool; Drug Therapy, Combina | 1995 |
Catheter-related infections by Hansenula anomala in children.
Topics: Catheterization, Central Venous; Child; Child, Preschool; Female; Fluconazole; Fungemia; Humans; Imm | 1995 |
Pathogenesis and management of Candida infection syndromes in non-neutropenic patients.
Topics: Amphotericin B; Candidiasis; Clinical Trials as Topic; Cross Infection; Fluconazole; Flucytosine; Fu | 1993 |
The role of azoles in the treatment and prophylaxis of cryptococcal disease in HIV infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Cryptococcosis; Fluconazole; Fungemia; Humans | 1994 |
Candida tropicalis infections in children with leukemia.
Topics: Abscess; Adolescent; Amphotericin B; Candida; Candidiasis; Cerebrospinal Fluid; Child; Child, Presch | 1993 |
Problems and controversies in the management of hematogenous candidiasis.
Topics: Algorithms; Amphotericin B; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Colony- | 1996 |
Spondylodiskitis due to Candida albicans: report of two patients who were successfully treated with fluconazole and review of the literature.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Discitis; Female; Fluconazole; Fungemia; Humans; K | 1996 |
Invasive infections due to Clavispora lusitaniae.
Topics: Adult; Amphotericin B; Antifungal Agents; Child, Preschool; Fluconazole; Fungemia; Humans; Meningiti | 1999 |
Nosocomial Candida krusei fungemia in cancer patients: report of 10 cases and review.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluco | 1999 |
The challenge of invasive fungal infection.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Aspergillosis; Candidiasis | 1999 |
Trichosporon beigelii infection: experience in a regional burn center.
Topics: Adult; Amphotericin B; Antifungal Agents; Burns; Catheters, Indwelling; Drug Resistance, Microbial; | 2000 |
Prevention of systemic mycoses in patients who are not neutropenic: should we do it? Can we do it?
Topics: Antifungal Agents; Clinical Trials as Topic; Fluconazole; Fungemia; Humans; Neutropenia; Risk Factor | 2000 |
Epidemiology and treatment of hematogenous candidiasis: a Brazilian perspective.
Topics: Amphotericin B; Antifungal Agents; Brazil; Candida; Candidiasis; Cross Infection; Fluconazole; Funge | 2000 |
[Visceral candidiasis].
Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Female | 2001 |
Nosocomial fungemia due to amphotericin B-resistant Candida spp. in three pediatric patients after previous neurosurgery for brain tumors.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Brain Neoplasms; Candida; Candidiasis; Catheterizatio | 2001 |
Fluconazole vs. amphotericin B for the management of candidaemia in adults: a meta-analysis.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clinical Trials as Topic; Fluconazol | 2001 |
Current strategies for treating invasive candidiasis: emphasis on infections in nonneutropenic patients.
Topics: Amphotericin B; Animals; Candidiasis; Cross Infection; Fluconazole; Fungemia; Humans | 1992 |
25 trials available for fluconazole and Fungemia
| Article | Year |
|---|---|
No difference between posaconazole and fluconazole antifungal prophylaxis and mycological diagnostics except costs in patients undergoing AML chemotherapy: a 1-year "real-life" evaluation.
Topics: Adult; Aged; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Clinical Laboratory | 2014 |
Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Critical Care; Cross Infection; Double-Blind Method; Fe | 2008 |
The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
Topics: Academic Medical Centers; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida gla | 2009 |
A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catheterization; Double-Blind Method | 2003 |
A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.
Topics: Adolescent; Adult; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Cohort S | 2003 |
Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study.
Topics: Antifungal Agents; Candidiasis; Child; Child, Preschool; Cross Infection; Double-Blind Method; Femal | 2004 |
Fluconazole MIC and the fluconazole dose/MIC ratio correlate with therapeutic response among patients with candidemia.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Child, Preschool; Dose-Response Re | 2005 |
Fluconazole prophylaxis for critically ill patients at high risk for Candida infection.
Topics: Antifungal Agents; Candidiasis; Critical Illness; Fluconazole; Fungemia; Humans | 2005 |
Diagnostic potential of (1,3)-beta-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anemia, Aplastic; Antibodies, Fungal; Antibody Specificity; | 2006 |
Anidulafungin versus fluconazole for invasive candidiasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; | 2007 |
Anidulafungin versus fluconazole for invasive candidiasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; | 2007 |
Anidulafungin versus fluconazole for invasive candidiasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; | 2007 |
Anidulafungin versus fluconazole for invasive candidiasis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis; | 2007 |
Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group.
Topics: Amphotericin B; Candida; Candidiasis; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests | 1995 |
A randomized trial comparing fluconazole with amphotericin B for the treatment of candidemia in patients without neutropenia. Candidemia Study Group and the National Institute.
Topics: Amphotericin B; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Follow-Up Studies; Fungemia | 1994 |
Efficacy and safety of fluconazole in the treatment of systemic fungal infections in pediatric patients. Multicentre Study Group.
Topics: Adolescent; Age Factors; AIDS-Related Opportunistic Infections; Candida; Candidiasis; Child; Child, | 1994 |
Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antigens, Fungal; Biomarkers; | 1994 |
Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antigens, Fungal; Biomarkers; | 1994 |
Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antigens, Fungal; Biomarkers; | 1994 |
Measurement of cryptococcal antigen in serum and cerebrospinal fluid: value in the management of AIDS-associated cryptococcal meningitis.
Topics: Acute Disease; AIDS-Related Opportunistic Infections; Amphotericin B; Antigens, Fungal; Biomarkers; | 1994 |
[A clinical study of fluconazole in the treatment of systemic mycosis associated with immunocompromised children].
Topics: Candidiasis; Child; Female; Fluconazole; Fungemia; Humans; Immune Tolerance; Immunologic Deficiency | 1994 |
Candiduria as an early marker of disseminated infection in critically ill surgical patients: the role of fluconazole therapy.
Topics: Adult; Aged; Amphotericin B; Bacterial Infections; Candidiasis; Cause of Death; Colony Count, Microb | 1993 |
Management of candida septicaemia in a regional burn unit.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Burn Units; Burns; Candidiasis; Child; F | 1995 |
Fluconazole versus amphotericin B in the treatment of hematogenous candidiasis: a matched cohort study.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Case-Control Studies; Female; Fluconazo | 1996 |
Fluconazole vs. amphotericin B for the treatment of neonatal fungal septicemia: a prospective randomized trial.
Topics: Administration, Oral; Amphotericin B; Antifungal Agents; Developing Countries; Drug Administration S | 1996 |
Candidemia in non-neutropenic critically ill patients: analysis of prognostic factors and assessment of systemic antifungal therapy. Study Group of Fungal Infection in the ICU.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; APACHE; Candidiasis; | 1997 |
Multicenter randomized trial of fluconazole versus amphotericin B for treatment of candidemia in non-neutropenic patients. Canadian Candidemia Study Group.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Confidence Intervals; Female; Fluconazo | 1997 |
Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.
Topics: Adult; Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Antibiotic Prophylaxis; A | 1998 |
Economic analysis of fluconazole versus amphotericin B for the treatment of candidemia in non-neutropenic patients.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Health C | 1998 |
Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Aspergillosis; | 2000 |
Efficacy of fluconazole in the treatment of systemic fungal infections.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aspergillosis; Candidiasis; Female; Fluconazole; Fungemi | 1992 |
304 other studies available for fluconazole and Fungemia
| Article | Year |
|---|---|
Association of fluconazole area under the concentration-time curve/MIC and dose/MIC ratios with mortality in nonneutropenic patients with candidemia.
Topics: Adult; Aged; Antifungal Agents; Area Under Curve; Candida; Candidiasis; Female; Fluconazole; Fungemi | 2007 |
Antifungal drug susceptibility profile of Pichia anomala isolates from patients presenting with nosocomial fungemia.
Topics: Amphotericin B; Antifungal Agents; Cross Infection; Fluconazole; Fungemia; Humans; Itraconazole; Mic | 2007 |
In vitro activities of isavuconazole and other antifungal agents against Candida bloodstream isolates.
Topics: Antifungal Agents; Area Under Curve; Candida; Fungemia; Humans; Microbial Sensitivity Tests; Nitrile | 2007 |
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Aspergillosis; Aspergillus; Candida; Candidiasis | 2008 |
Prevalence and susceptibility profile of Candida metapsilosis and Candida orthopsilosis: results from population-based surveillance of candidemia in Spain.
Topics: Antifungal Agents; Candida; Candidiasis; Fungemia; Humans; Microbial Sensitivity Tests; Population S | 2008 |
Reduced Candida glabrata susceptibility secondary to an FKS1 mutation developed during candidemia treatment.
Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Caspofungin; Drug Resistance, Fungal; Echino | 2008 |
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida tropicalis; Candidiasis; Caspofungin; Drug Resis | 2008 |
Acquisition of flucytosine, azole, and caspofungin resistance in Candida glabrata bloodstream isolates serially obtained from a hematopoietic stem cell transplant recipient.
Topics: Antifungal Agents; Azoles; Candida glabrata; Candidiasis; Caspofungin; Child; Drug Resistance, Funga | 2010 |
Epidemiological Characteristics and Drug Resistance of Fungemia in General Hospitals from 2010 to 2019.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; China; Cross Infection; Drug Resistance, | 2021 |
First case of neonatal fungemia caused by Aureobasidium melanogenum.
Topics: Antifungal Agents; Aureobasidium; Candida; Fluconazole; Fungemia; Humans; Infant, Newborn; Microbial | 2023 |
Genomic Analyses of a Fungemia Outbreak Caused by Lodderomyces elongisporus in a Neonatal Intensive Care Unit in Delhi, India.
Topics: Adult; Antifungal Agents; Birth Weight; Disease Outbreaks; Fluconazole; Fungemia; Genomics; Humans; | 2023 |
Yeasts from blood cultures in the wake of the COVID-19 pandemic in a tertiary care hospital: Shift in species epidemiology, steady low antifungal resistance and full in vitro ibrexafungerp activity.
Topics: Animals; Antifungal Agents; Blood Culture; Candida; Candida albicans; Candida glabrata; Candida para | 2023 |
Distribution of fungemia agents in five years and antifungal resistance.
Topics: Antifungal Agents; Candida; Candida albicans; Fluconazole; Fungemia; Humans | 2023 |
Case report: nosocomial fungemia caused by Candida diddensiae.
Topics: Anti-Bacterial Agents; Antifungal Agents; Candida; Central Venous Catheters; Cross Infection; DNA, R | 2020 |
Cryptococcal meningitis in an immunocompetent patient.
Topics: Adult; Amphotericin B; Antifungal Agents; Culture Techniques; Delayed Diagnosis; Fluconazole; Flucyt | 2020 |
Candidal Prosthetic Hip Infection in a Patient with Previous Candidal Sepsis - A Case Report.
Topics: Arthrocentesis; Arthroplasty, Replacement, Hip; Candida tropicalis; Candidiasis; Debridement; Female | 2020 |
Successful Treatment of Breakthrough Trichosporon asahii Fungemia by the Combination Therapy of Fluconazole and Liposomal Amphotericin B in a Patient with Follicular Lymphoma.
Topics: Amphotericin B; Antifungal Agents; Basidiomycota; Fluconazole; Fungemia; Humans; Lymphoma, Follicula | 2021 |
Monitoring the Epidemiology and Antifungal Resistance of Yeasts Causing Fungemia in a Tertiary Care Hospital in Madrid, Spain: Any Relevant Changes in the Last 13 Years?
Topics: Antifungal Agents; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tes | 2021 |
Pacemaker-related
Topics: Antifungal Agents; Candida parapsilosis; Female; Fluconazole; Fungemia; Humans; Kidney Transplantati | 2021 |
Fatal course of Saprochaete capitata fungemia in children with acute lymphoblastic leukemia.
Topics: Adolescent; Child; Child, Preschool; Echinocandins; Fatal Outcome; Female; Fluconazole; Fungemia; Hu | 2017 |
Fungemia associated with Schizophyllum commune in Brazil.
Topics: Amphotericin B; Antifungal Agents; Deoxycholic Acid; Drug Combinations; Fluconazole; Fungemia; Human | 2017 |
Update from a 12-Year Nationwide Fungemia Surveillance: Increasing Intrinsic and Acquired Resistance Causes Concern.
Topics: Age Factors; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candida albicans; | 2018 |
Comparison of the incidence, clinical features and outcomes of invasive candidiasis in children and neonates.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis, Invasive; Caspofungin; | 2018 |
Emergency of fungemia cases caused by fluconazole-resistant Candida auris in Beijing, China.
Topics: Antifungal Agents; Candida; Candidiasis; China; Drug Resistance, Fungal; Fluconazole; Fungemia; Huma | 2018 |
First fungemia case due to environmental yeast Wickerhamomyces myanmarensis: detection by multiplex qPCR and antifungal susceptibility.
Topics: Antifungal Agents; Child; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Male; Microbial Se | 2019 |
Malassezia furfur Emergence and Candidemia Trends in a Neonatal Intensive Care Unit During 10 Years: The Experience of Fluconazole Prophylaxis in a Single Hospital.
Topics: Antifungal Agents; Candidemia; Female; Fluconazole; Forecasting; Fungemia; Humans; Infant; Infant, N | 2020 |
Histopathological evaluation of the efficacy of antifungals for experimental Trichosporon bloodstream infection.
Topics: Amphotericin B; Animals; Antifungal Agents; Colony Count, Microbial; Disease Models, Animal; Flucona | 2013 |
In vitro antifungal activities of amphotericin B, 5-fluorocytosine, fluconazole and itraconazole against Cryptococcus neoformans isolated from cerebrospinal fluid and blood from patients in Serbia.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cerebrospinal Fluid; Cross | 2012 |
Small chromosomes among Danish Candida glabrata isolates originated through different mechanisms.
Topics: Antifungal Agents; Base Sequence; Candida glabrata; Candidiasis; Chromosomes, Fungal; Cross Infectio | 2013 |
[Saccharomyces cerevisiae fungemia in a premature neonate treated receiving probiotics].
Topics: Antifungal Agents; Apnea; Candidemia; Catheter-Related Infections; Diagnosis, Differential; Equipmen | 2013 |
New clonal strain of Candida auris, Delhi, India.
Topics: Aged; Antifungal Agents; Candida; Candidiasis; Child; DNA, Fungal; DNA, Ribosomal Spacer; Drug Resis | 2013 |
Scedosporium prolificans fungaemia in a patient with acute lymphoblastic leukaemia.
Topics: Allografts; Amphotericin B; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone | 2013 |
Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations.
Topics: Adolescent; Adult; Aged; Amphotericin B; Anti-Infective Agents; Bacteremia; Candidiasis; Child; Chil | 2014 |
Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
Topics: Acyclovir; Adolescent; Adult; Anti-Infective Agents; Bacteremia; Candida albicans; Candidiasis; Cath | 2014 |
Fungemia due to Lachancea fermentati: a case report.
Topics: Adult; Antifungal Agents; Echinocandins; Fluconazole; Fungemia; Hepatitis, Alcoholic; Humans; Immuno | 2014 |
A novel scoring system to predict the incidence of invasive fungal disease in salvage chemotherapies for malignant lymphoma.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; C | 2014 |
Species distribution and susceptibility profile to fluconazole, voriconazole and MXP-4509 of 551 clinical yeast isolates from a Romanian multi-centre study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Child; Child, Preschool; Dru | 2015 |
Beyond the superficial: Coccidioides immitis fungaemia in a man with fever, fatigue and skin nodules: a case of an emerging and evolving pathogen.
Topics: Antifungal Agents; Coccidioidomycosis; Communicable Diseases, Emerging; Diagnosis, Differential; Fat | 2014 |
Evaluation of VT-1161 for Treatment of Coccidioidomycosis in Murine Infection Models.
Topics: 14-alpha Demethylase Inhibitors; Animals; Antifungal Agents; Coccidioides; Coccidioidomycosis; Disea | 2015 |
[Multiple facial nodules revealing disseminated cryptococcosis in an immunocompetent patient].
Topics: Adult; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococcus gattii; Facial Dermatoses; Fa | 2016 |
Resistance Mechanisms and Clinical Features of Fluconazole-Nonsusceptible Candida tropicalis Isolates Compared with Fluconazole-Less-Susceptible Isolates.
Topics: Amino Acid Substitution; Antifungal Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; | 2016 |
[Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Topics: Antifungal Agents; Candida; Candidiasis, Invasive; Dose-Response Relationship, Drug; Drug Resistance | 2016 |
Cryptococcal cellulitis on the shin of an immunosuppressed patient.
Topics: Amphotericin B; Antifungal Agents; Cellulitis; Cryptococcosis; Cryptococcus neoformans; Cyclosporine | 2016 |
Saccharomyces boulardii probiotic-associated fungemia: questioning the safety of this preventive probiotic's use.
Topics: Antifungal Agents; Diarrhea; Fluconazole; Fungemia; Humans; Male; Middle Aged; Mycological Typing Te | 2017 |
Invasive infections due to Saprochaete and Geotrichum species: Report of 23 cases from the FungiScope Registry.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Echinocandins; Female; Fluconazole; Fung | 2017 |
Association of fluconazole pharmacodynamics with mortality in patients with candidemia.
Topics: Adult; Aged; Antifungal Agents; APACHE; Candida; Candidiasis; Dose-Response Relationship, Drug; Drug | 2008 |
The answer is in: fluconazole prophylaxis is not beneficial for intensive care unit patients without neutropenia.
Topics: Antifungal Agents; Candidiasis; Critical Care; Cross Infection; Fluconazole; Fungemia; Humans; Inten | 2008 |
Prevention of invasive Candida infections in preterm infants: the time is now.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Fungemia; Gestational Age; Humans; Infant, Newborn; Inf | 2008 |
Multiple septic complications of disseminated candidiasis following anorectal sepsis in a non-immunocompromised patient.
Topics: Aged, 80 and over; Antifungal Agents; Anus Diseases; Candida albicans; Candidiasis; Epididymitis; Fl | 2008 |
Pattern of Candida isolates in hospitalized children.
Topics: Antifungal Agents; Candida; Candidiasis; Child; Child, Hospitalized; Child, Preschool; Cross Infecti | 2008 |
[Case report: Analysis of the critical time delays from the fever increase to the first antimycotic dose during the diagnosis of candidemia].
Topics: Aged, 80 and over; Antifungal Agents; Candida albicans; Candidiasis; Female; Fluconazole; Fungemia; | 2008 |
Fungaemia caused by Candida glabrata with reduced susceptibility to fluconazole due to altered gene expression: risk factors, antifungal treatment and outcome.
Topics: Aged; Antifungal Agents; Candida glabrata; Candidiasis; Case-Control Studies; Drug Resistance, Funga | 2008 |
Take control over your fluconazole prescriptions: the growing importance of Candida glabrata as an agent of candidemia in Brazil.
Topics: Antifungal Agents; Brazil; Candida; Candida glabrata; Candidiasis; Fluconazole; Fungemia; Humans; In | 2008 |
A case of Candida lambica fungemia misidentified as Candida krusei in an intravenous drug abuser.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Diagnostic Errors; Drug Resistance, Fungal; | 2008 |
Treatment-related risk factors for hospital mortality in Candida bloodstream infections.
Topics: Antifungal Agents; Candidiasis; Catheterization, Central Venous; Catheters, Indwelling; Cohort Studi | 2008 |
Empirical treatment of candidemia in intensive care units: fluconazole or broad-spectrum antifungal agents?
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Child; Drug Resistance, Fungal; Fluconazole; Fungemi | 2009 |
Neonatal candidaemia in Kuwait: a 12-year study of risk factors, species spectrum and antifungal susceptibility.
Topics: Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Fungemia; Humans; Infant, Newborn; Int | 2009 |
Risk-based fluconazole prophylaxis of Candida bloodstream infection in a medical intensive care unit.
Topics: Adult; Animals; Antifungal Agents; Candidiasis; Chemoprevention; Dialysis; Fluconazole; Fungemia; He | 2009 |
Risk factors for fluconazole-resistant Candida glabrata bloodstream infections.
Topics: Adult; Aged; Antifungal Agents; Candida glabrata; Case-Control Studies; Comorbidity; Drug Resistance | 2009 |
Candida glabrata fungaemia in a tertiary centre in Taiwan: antifungal susceptibility and outcomes.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida glabrata; Drug Resistance, Fungal; Female | 2009 |
Initial treatment and outcome of Candida glabrata versus Candida albicans bloodstream infection.
Topics: Aged; Aged, 80 and over; Animals; Antifungal Agents; Candida albicans; Candida glabrata; Candidiasis | 2009 |
Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; | 2009 |
Association of fluconazole pharmacodynamics with mortality in patients with candidemia.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests | 2009 |
Fungaemia due to Cryptococcus laurentii as a complication of immunosuppressive therapy--a case report.
Topics: Adult; Antifungal Agents; Cryptococcosis; Cryptococcus; Fluconazole; Fungemia; Glomerulonephritis, M | 2009 |
Catheter-related fungemia caused by Candida intermedia.
Topics: Adult; Aged, 80 and over; Antifungal Agents; Blood; Candida; Candidiasis; Catheterization, Central V | 2010 |
Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation.
Topics: Antifungal Agents; Candidiasis; Cost-Benefit Analysis; Cross Infection; Decision Trees; Drug Costs; | 2009 |
The increased role of non-albicans species in candidaemia: results from a 3-year surveillance study.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Mic | 2010 |
Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Chemoprevention; Cross-Over Studies; Drug Util | 2009 |
Fluconazole use as an important risk factor in the emergence of fluconazole-resistant Candida glabrata fungemia.
Topics: Antifungal Agents; Candida glabrata; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Risk Fa | 2009 |
Blood stream infections by Candida glabrata and Candida krusei: a single-center experience.
Topics: Adult; Aged; APACHE; Candida glabrata; Candidiasis; Female; Fluconazole; Fungemia; Humans; Incidence | 2009 |
Comparison of antifungal MICs for yeasts obtained using the EUCAST method in a reference laboratory and the Etest in nine different hospital laboratories.
Topics: Amphotericin B; Antifungal Agents; Candida; Caspofungin; Cryptococcus neoformans; Drug Resistance, F | 2010 |
Candida rugosa: a distinctive emerging cause of candidaemia. A case report and review of the literature.
Topics: Antifungal Agents; Candida; Candidiasis; Catheters, Indwelling; Crohn Disease; Fluconazole; Fungemia | 2009 |
Cryptococcal meningitis with an antecedent cutaneous Cryptococcal lesion.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Carbon; Coloring Agents; Cryptococcosis; Cryptococcus | 2009 |
Early prediction of Candida glabrata fungemia in nonneutropenic critically ill patients.
Topics: Adult; Aged; Antifungal Agents; Candida glabrata; Candidiasis; Cohort Studies; Critical Care; Critic | 2010 |
Cutaneous cryptococcosis in solid organ transplant recipients.
Topics: Antifungal Agents; Central Nervous System Fungal Infections; Cohort Studies; Cryptococcosis; Cryptoc | 2010 |
The impact of delaying the initiation of appropriate antifungal treatment for Candida bloodstream infection.
Topics: Adult; Aged; Aged, 80 and over; Analysis of Variance; Antifungal Agents; APACHE; Candida; Candidiasi | 2010 |
Changing trends in the epidemiology of Candida blood stream infections: a matter for concern?
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Critical Care; Cross-Sectional Studies; Drug Resis | 2010 |
Candidaemia in adult cancer patients: risks for fluconazole-resistant isolates and death.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Drug Resistance | 2010 |
Prior antimicrobial exposure and the risk for bloodstream infection with fluconazole-non-susceptible Candida strains.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Ciprofloxacin; Drug Resistance, Fungal; Fluconazole; | 2010 |
New onset of bilateral multifocal coccidioidomycosal choroiditis in a patient on oral fluconazole.
Topics: Administration, Oral; Antifungal Agents; Choroiditis; Coccidioides; Coccidioidomycosis; Eye Infectio | 2010 |
Increasing incidence of candidaemia: long-term epidemiological trends, Queensland, Australia, 1999-2008.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; | 2010 |
Candida krusei fungemia in an immunocompromised patient.
Topics: Antifungal Agents; Candida; Candidiasis, Cutaneous; Fluconazole; Fungemia; Humans; Immunocompromised | 2010 |
Candidaemia associated with decreased in vitro fluconazole susceptibility: is Candida speciation predictive of the susceptibility pattern?
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Female; Fluconazole; Fungem | 2010 |
Risk factors for fluconazole-resistant candidemia.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fun | 2010 |
Aureobasidium pullulans var. melanigenum fungemia in a pediatric patient.
Topics: Amphotericin B; Antifungal Agents; Ascomycota; Blood; Catheter-Related Infections; Child; DNA, Funga | 2011 |
Association of fungal sepsis and galactosemia.
Topics: Antifungal Agents; Candida; Fluconazole; Fungemia; Galactosemias; Genetic Heterogeneity; Humans; Inf | 2010 |
Clinical and economic outcomes of decreased fluconazole susceptibility in patients with Candida glabrata bloodstream infections.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida glabrata; Candidiasis; Cohort Studies; Dr | 2010 |
Case report 6: Candidaemia in a high risk liver transplant recipient.
Topics: Anidulafungin; Anti-Bacterial Agents; Antifungal Agents; Bacteremia; Bronchitis; Candida albicans; C | 2010 |
Secular trend in candidemia and the use of fluconazole in Finland, 2004-2007.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Chemoprevention | 2010 |
Endogenous candida chorioretinitis in a healthy infant.
Topics: Antifungal Agents; Candida; Candidiasis; Chorioretinitis; Eye Infections, Fungal; Female; Fluconazol | 2010 |
Comparative in vitro activities of fluconazole, voriconazole, and MXP-4509 against Romanian blood yeast isolates.
Topics: Antifungal Agents; Blood; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Pyrimidines; R | 2011 |
Long-term surveillance and treatment of subclinical cryptococcosis and nasal colonization by Cryptococcus neoformans and C. gattii species complex in captive koalas (Phascolarctes cinereus).
Topics: Amphotericin B; Animals; Animals, Zoo; Antifungal Agents; Carrier State; Cryptococcosis; Cryptococcu | 2012 |
Recurrent Saccharomyces cerevisiae fungemia in an otherwise healthy patient.
Topics: Abdominal Pain; Adult; Amphotericin B; Antifungal Agents; Chills; Diagnosis, Differential; Female; F | 2011 |
Is elevation of the serum β-d-glucan level a paradoxical sign for trichosporon fungemia in patients with hematologic disorders?
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; beta-Glucans; Echinoc | 2012 |
Donor-derived organ transplant transmission of coccidioidomycosis.
Topics: Adolescent; Antifungal Agents; Coccidioides; Coccidioidomycosis; Fatal Outcome; Female; Fluconazole; | 2012 |
Microbiology and epidemiology of oral yeast colonization in hemopoietic progenitor cell transplant recipients.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Candida; Candida albicans; Candida glab | 2013 |
Disseminated cryptococcal infection in rheumatoid arthritis treated with methotrexate and infliximab.
Topics: Aged; Antibodies, Monoclonal; Arthritis, Rheumatoid; Cryptococcosis; Cryptococcus neoformans; Dose-R | 2002 |
Prospective, multicenter surveillance study of Candida glabrata: fluconazole and itraconazole susceptibility profiles in bloodstream, invasive, and colonizing strains and differences between isolates from three urban teaching hospitals in New York City (C
Topics: Antifungal Agents; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Ho | 2002 |
Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital.
Topics: Adolescent; Adult; Age Distribution; Aged; Antifungal Agents; Candidiasis; Causality; Comorbidity; C | 2002 |
Frequency and clinical significance of bloodstream infections caused by C albicans strains with reduced susceptibility to fluconazole.
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Follow-Up Studies; | 2002 |
Saccharomyces cerevisiae-associated diarrhea in an immunocompetent patient with ulcerative colitis.
Topics: Adult; Antibodies, Fungal; Antifungal Agents; Colitis, Ulcerative; Diarrhea; Fluconazole; Fungemia; | 2003 |
[Treatment approach for fungal infections in critically ill patients admitted to intensive care units: results of a multicenter survey].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Case Management; Consensus Development Conferences a | 2003 |
[Infections by Candida sp. in intensive care. Survey of French practices].
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Cross-Sectional Stu | 2003 |
Evaluation of the Etest and disk diffusion methods for determining susceptibilities of 235 bloodstream isolates of Candida glabrata to fluconazole and voriconazole.
Topics: Agar; Antifungal Agents; Candida glabrata; Candidiasis; Culture Media; Fluconazole; Fungemia; Humans | 2003 |
Variation in susceptibility of bloodstream isolates of Candida glabrata to fluconazole according to patient age and geographic location.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Candida glabrata; Candid | 2003 |
Fluconazole plus amphotericin B combinations are not contraindicated and may add benefit for the treatment of candidemia.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Drug Therapy, Combination; Fluconazole; Fungemia; Hu | 2003 |
Breakthrough fungemia caused by azole-resistant Candida albicans in neutropenic patients with acute leukemia.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Antineoplastic Age | 2003 |
Successful treatment of Candida krusei infection with caspofungin acetate: a new antifungal agent.
Topics: Adult; Amphotericin B; Anti-Bacterial Agents; Antifungal Agents; Candida; Candidiasis; Caspofungin; | 2003 |
Candidemia in women with breast carcinoma treated with high-dose chemotherapy and autologous bone marrow transplantation.
Topics: Adult; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantatio | 2003 |
Antifungal susceptibility testing of Candida albicans by flow cytometry.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Flow Cytometry; Fluconazole; Funge | 2003 |
Susceptibility profile of 200 bloodstream isolates of Candida spp. collected from Brazilian tertiary care hospitals.
Topics: Amphotericin B; Antifungal Agents; Brazil; Candida; Candida albicans; Candidiasis; Drug Resistance, | 2003 |
Attributable mortality of nosocomial candidemia, revisited.
Topics: Age Factors; Antifungal Agents; Candida; Candidiasis; Cohort Studies; Cross Infection; Female; Fluco | 2003 |
Candidaemia in a London teaching hospital: analysis of 128 cases over a 7-year period.
Topics: Antifungal Agents; Brain Abscess; Candidiasis; Cross Infection; Drug Resistance, Fungal; Endocarditi | 2003 |
Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000.
Topics: Antifungal Agents; Candidiasis; Cross Infection; Data Collection; Drug Resistance, Microbial; Flucon | 2004 |
Distribution and antifungal susceptibility of Candida species causing candidemia from 1996 to 1999.
Topics: Amphotericin B; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Microb | 2004 |
In vitro susceptibilities of rare Candida bloodstream isolates to ravuconazole and three comparative antifungal agents.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Flucy | 2004 |
High-dose fluconazole therapy for cancer patients with solid tumors and candidemia: an observational, noncomparative retrospective study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Do | 2004 |
Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit.
Topics: Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Antifungal Agents; Candidiasis; Female; Fluc | 2003 |
Clinical factors associated with fluconazole resistance and short-term survival in patients with Candida bloodstream infection.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Blood; Candida; Candidiasis; Child; C | 2004 |
Pichia anomala fungaemia in immunocompromised children.
Topics: Adolescent; Antifungal Agents; Child; Female; Fluconazole; Fungemia; Humans; Immunocompromised Host; | 2004 |
[Indications for antifungal treatment in intensive care unit patients].
Topics: Antifungal Agents; APACHE; Candidiasis; Comorbidity; Critical Care; Cross Infection; Fluconazole; Fu | 2004 |
[Peripheral thrombophlebitis in a patient undergoing abdominal surgery].
Topics: Administration, Oral; Aged; Antifungal Agents; Candida albicans; Candidiasis; Catheterization, Centr | 2004 |
Species distribution and fluconazole susceptibility of Candida clinical isolates in a medical center in 2002.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Mic | 2004 |
Sequestration and late activation of lenticular Candida abscess in premature infants.
Topics: Abscess; Amphotericin B; Antifungal Agents; Candidiasis; Cataract Extraction; Eye Infections, Fungal | 2004 |
Utility of real-time antifungal susceptibility testing for fluconazole in the treatment of candidemia.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Bacteriological Techniques; Candid | 2004 |
Candidaemia in allogeneic stem cell transplant recipients: low risk without fluconazole prophylaxis.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Graft vs Hos | 2004 |
Assessment of preemptive treatment to prevent severe candidiasis in critically ill surgical patients.
Topics: Adult; Age Distribution; Aged; APACHE; Candidiasis; Case-Control Studies; Chi-Square Distribution; C | 2004 |
Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit?
Topics: Candidiasis; Case-Control Studies; Critical Care; Cross Infection; Female; Fluconazole; Fungemia; Hu | 2004 |
Antifungal activities of R-135853, a sordarin derivative, in experimental candidiasis in mice.
Topics: Animals; Antifungal Agents; Azepines; Bridged-Ring Compounds; Candida; Candida albicans; Candidiasis | 2005 |
Disseminated coccidioidomycosis.
Topics: Aged; Antifungal Agents; Coccidioides; Coccidioidomycosis; Drug Resistance, Fungal; Fluconazole; Fun | 2005 |
CHROMagar Candida medium for direct susceptibility testing of yeast from blood cultures.
Topics: Agar; Antifungal Agents; Blood; Candida; Candidiasis; Chromogenic Compounds; Culture Media; Fluconaz | 2005 |
Epidemiology and predictors of mortality in cases of Candida bloodstream infection: results from population-based surveillance, barcelona, Spain, from 2002 to 2003.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Child; Child, P | 2005 |
Emergence of fluconazole resistance in a Candida parapsilosis strain that caused infections in a neonatal intensive care unit.
Topics: Antifungal Agents; Candida; Candidiasis; Chemoprevention; Drug Resistance, Fungal; Female; Fluconazo | 2005 |
Species distribution and antifungal susceptibility of Candida bloodstream isolates in a tertiary medical center in Israel.
Topics: Academic Medical Centers; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glab | 2005 |
Breakthrough Candida krusei fungemia during fluconazole prophylaxis followed by breakthrough zygomycosis during caspofungin therapy in a patient with severe aplastic anemia who underwent stem cell transplantation.
Topics: Adolescent; Anemia, Aplastic; Antifungal Agents; Candida; Candidiasis; Caspofungin; Chemoprevention; | 2005 |
Candida glabrata fungemia in transplant patients receiving voriconazole after fluconazole.
Topics: Adolescent; Adult; Candida glabrata; Female; Fluconazole; Fungemia; Humans; Leukemia; Male; Microbia | 2005 |
Secular trends in nosocomial candidaemia in non-neutropenic patients in an Italian tertiary hospital.
Topics: Antifungal Agents; Candida; Candidiasis; Catheters, Indwelling; Cross Infection; Drug Resistance, Fu | 2005 |
Experience with caspofungin in the treatment of persistent fungemia in neonates.
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Caspofungin; Drug Therapy, Combination; Echinocandin | 2005 |
Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study.
Topics: Anti-Infective Agents; Candida glabrata; Candidiasis; Case-Control Studies; Cross Infection; Female; | 2005 |
Survival of candida sepsis in extracorporeal membrane oxygenation.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Endocarditis; Extracorporeal Memb | 2005 |
Etiology of fungaemia and catheter colonisation in Argentinean paediatric patients.
Topics: Adolescent; Amphotericin B; Antifungal Agents; Argentina; Candida; Catheterization; Child; Child, Pr | 2006 |
Effects of cessation of a policy of neonatal fluconazole prophylaxis on fungal resurgence.
Topics: Antifungal Agents; Female; Fluconazole; Fungemia; Humans; Incidence; India; Infant, Newborn; Intensi | 2005 |
Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy.
Topics: Antifungal Agents; Blood; Candida; Candida glabrata; Candidiasis; Drug Resistance, Fungal; Fatal Out | 2006 |
Breakthrough fungemia caused by fluconazole-resistant Candida albicans with decreased susceptibility to voriconazole in patients with hematologic malignancies.
Topics: Candida albicans; Candidiasis; Drug Resistance; Fluconazole; Fungemia; Hematologic Neoplasms; Humans | 2006 |
Epidemiological trends in nosocomial candidemia in intensive care.
Topics: Adult; Aged; Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Utilization; Female; Flu | 2006 |
Recurrent candidaemia in a neonate with Hirschsprung's disease: fluconazole resistance and genetic relatedness of eight Candida tropicalis isolates.
Topics: Antifungal Agents; Candida tropicalis; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; | 2006 |
Risk factors for candidemia-related mortality at a medical center in central Taiwan.
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Anti-Bacterial Agents; APACHE; Candida; Candidiasis; | 2006 |
Trichosporon asahii fungemia in a patient with non-hematological malignancy.
Topics: Aged; Antifungal Agents; Carcinoma, Transitional Cell; Caspofungin; Cystectomy; Drug Resistance, Mul | 2006 |
Changing incidence of Candida bloodstream infections among NICU patients in the United States: 1995-2004.
Topics: Antifungal Agents; Birth Weight; Candida; Candidiasis; Cross Infection; Drug Resistance, Fungal; Flu | 2006 |
Candidaemia and antifungal therapy in a French University Hospital: rough trends over a decade and possible links.
Topics: Antifungal Agents; Biological Evolution; Candida; Candida albicans; Candida glabrata; Candidiasis; F | 2006 |
Clinical significance of azole antifungal drug cross-resistance in Candida glabrata.
Topics: Adult; Antifungal Agents; Candida glabrata; Candidiasis; Child; Drug Resistance, Fungal; Fluconazole | 2006 |
Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candidiasis; Cross Infection; Female; Fluconazole | 2006 |
The association between anatomic site of Candida colonization, invasive candidiasis, and mortality in critically ill surgical patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; APACHE; Candida; Candidiasis; Critica | 2006 |
Rhodotorula glutinis fungemia successfully treated with fluconazole: report of two cases.
Topics: Aged; Antifungal Agents; Fluconazole; Fungemia; Humans; Male; Middle Aged; Rhodotorula | 2007 |
Breakthrough Fusarium sp probable pneumonia during fluconazole therapy in an AIDS patient with diabetes, candidemia, Pneumocystis carinii pneumonia and cytomegalovirus disseminated infection.
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Cytomegalovirus Infections; D | 2006 |
Effect of fluconazole consumption on long-term trends in candidal ecology.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Drug Utilization; Fluconazole; Fungemia; H | 2006 |
Candidemia in Norway (1991 to 2003): results from a nationwide study.
Topics: Adolescent; Adult; Age Distribution; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida al | 2006 |
Time to initiation of fluconazole therapy impacts mortality in patients with candidemia: a multi-institutional study.
Topics: Adult; Aged; Antifungal Agents; Candidiasis; Cohort Studies; Female; Fluconazole; Fungemia; Humans; | 2006 |
Candida pseudohaemulonii Sp. Nov., an amphotericin B-and azole-resistant yeast species, isolated from the blood of a patient from Thailand.
Topics: Amphotericin B; Antifungal Agents; Candida; Drug Resistance, Fungal; Fluconazole; Fungemia; Microbia | 2006 |
Epidemiological study of Candida infections in blood: susceptibilities of Candida spp. to antifungal agents, and clinical features associated with the candidemia.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Female; F | 2006 |
[Profile of antifungal susceptibility of species of Candida isolated from hemocultures in a university hospital, Maracaibo, Venezuela].
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Funge | 2006 |
Fluconazole and itraconazole resistance of yeasts isolated from the bloodstream and catheters of hospitalized pediatric patients.
Topics: Adolescent; Antifungal Agents; Candida; Catheters, Indwelling; Child; Child, Preschool; Drug Resista | 2006 |
Epidemiology and outcome of Rhodotorula fungemia in a tertiary care hospital.
Topics: Adolescent; Adrenal Cortex Hormones; Adult; Anti-Bacterial Agents; Antifungal Agents; Antineoplastic | 2006 |
Epidemiology of candidemia in a Turkish tertiary care hospital.
Topics: Amphotericin B; Antifungal Agents; Blotting, Southern; Candida; Candidiasis; Cross Infection; DNA Fi | 2006 |
In vitro susceptibility of breakthrough Candida bloodstream isolates correlates with daily and cumulative doses of fluconazole.
Topics: Antifungal Agents; Blood; Candida; Candidiasis; Chemoprevention; Fluconazole; Fungemia; Humans; Micr | 2006 |
Fluconazole and itraconazole susceptibilities of Candida spp. isolated from oropharyngeal specimens and blood cultures of paediatric haematology/oncology patients.
Topics: Candida; Candidiasis; Fluconazole; Fungemia; Itraconazole; Leukemia; Microbial Sensitivity Tests; Or | 2006 |
[Candida krusei fungemia: do not ignore mycological diagnosis].
Topics: Adult; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Fungemia; Humans | 2007 |
The prophylactic effectiveness of various antifungal agents against the progression of trichosporonosis fungemia to disseminated disease in a neutropenic mouse model.
Topics: Amphotericin B; Animal Structures; Animals; Antibiotic Prophylaxis; Antifungal Agents; Cyclophospham | 2007 |
Echinocandins for candidemia.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Fungemia; Humans; Pyrimidines; Triazoles; Voriconazole | 2006 |
Efficacy of aminocandin in the treatment of immunocompetent mice with haematogenously disseminated fluconazole-resistant candidiasis.
Topics: Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Fungal; Female; Fluconaz | 2007 |
Inadequacy of fluconazole dosing in patients with candidemia based on Infectious Diseases Society of America (IDSA) guidelines.
Topics: Adult; Aged; Antifungal Agents; Body Weight; Candida; Candida glabrata; Candidiasis; Cohort Studies; | 2007 |
Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Cand | 2007 |
Paecilomyces lilacinus fungemia in a Jamaican neonate.
Topics: Amphotericin B; Antifungal Agents; Diagnosis, Differential; Female; Fluconazole; Fungemia; Humans; J | 2006 |
To test or not to test: a cost minimization analysis of susceptibility testing for patients with documented Candida glabrata fungemias.
Topics: Antifungal Agents; Candida glabrata; Costs and Cost Analysis; Decision Making; Fluconazole; Fungal P | 2007 |
Outbreak of fungemia among neonates caused by Candida haemulonii resistant to amphotericin B, itraconazole, and fluconazole.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Disease Outbreaks; Drug Resistance, Fungal; | 2007 |
Selective fluconazole prophylaxis in high-risk babies to reduce invasive fungal infection.
Topics: Antifungal Agents; Candidiasis; Chemoprevention; Drug Resistance, Fungal; Fluconazole; Fungemia; Hum | 2007 |
Echinocandins--first-choice or first-line therapy for invasive candidiasis?
Topics: Anidulafungin; Antifungal Agents; Candidiasis; Echinocandins; Fluconazole; Fungemia; Humans; Infant, | 2007 |
Rapid differentiation between fluconazole-sensitive and -resistant species of Candida directly from positive blood-culture bottles by real-time PCR.
Topics: Antifungal Agents; Blood; Candida; Candida albicans; Culture Media; DNA, Fungal; Drug Resistance, Fu | 2007 |
Persistence of Candida albicans candidemia in non-neutropenic surgical patients: management of a representative patient in the absence of second-line treatment guidelines.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Caspofungin; Drug Combinations; Echinocandins; | 2007 |
One year prospective survey of Candida bloodstream infections in Scotland.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bacterial Infections; Candida; Candidiasis; Catheters, I | 2007 |
Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Area Under Curve; Candida; Candidiasi | 2007 |
Catheter-related fungemia due to fluconazole-resistant Candida nivariensis.
Topics: Aged; Antifungal Agents; Candida; Catheterization, Central Venous; Drug Resistance, Fungal; Female; | 2007 |
Predominance of Candida tropicalis bloodstream infections in a Singapore teaching hospital.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Candida; Candida tropicalis; Candidia | 2007 |
[Biofilm production and antifungal susceptibility patterns of Candida species isolated from hospitalized patients].
Topics: Amphotericin B; Antifungal Agents; Biofilms; Candida; Candidiasis; Caspofungin; Drug Resistance, Fun | 2007 |
Cryptococcal meningoencephalitis diagnosed by blood culture.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cryptococcosis; Cryptococc | 2007 |
Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.
Topics: Antifungal Agents; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Hospitals; | 2008 |
EUCAST technical note on fluconazole.
Topics: Antifungal Agents; Area Under Curve; Candida; Candidiasis; Drug Resistance, Fungal; Fluconazole; Fun | 2008 |
Increasing incidence of Candida parapsilosis candidemia with caspofungin usage.
Topics: Academic Medical Centers; Antifungal Agents; Candida; Candidiasis; Caspofungin; Drug Resistance, Fun | 2008 |
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.
Topics: Africa; Antifungal Agents; Asia; Candida; Candidiasis; Drug Resistance, Fungal; Echinocandins; Europ | 2008 |
Candida dubliniensis meningitis as delayed sequela of treated C. dubliniensis fungemia.
Topics: Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocandins; Fluconazole; Fungemia; Heart Tr | 2008 |
Elevation of activated platelet-dependent chemokines and soluble cell adhesion molecules in patients with hematologic malignancies and high levels of beta-D-glucan.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Antineoplastic Combined Chemotherapy Protocols; b | 2007 |
[Clinical cases in medical mycology. Case no. 32].
Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Aspergillosis; Bacteremia; Bronchoalveolar | 2008 |
Breakthrough C. parapsilosis and C. guilliermondii blood stream infections in allogeneic hematopoietic stem cell transplant recipients receiving long-term caspofungin therapy.
Topics: Adolescent; Adult; Anemia, Aplastic; Antifungal Agents; Candida; Candidiasis; Caspofungin; Echinocan | 2008 |
The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Catheterization, Central Venous; Cohort Stu | 2008 |
A radiologic syndrome after high dose chemotherapy and autologous bone marrow transplantation, with clinical and pathologic features of systemic candidiasis.
Topics: Adult; Amphotericin B; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Purging; Bone Mar | 1994 |
Nosocomial Torulopsis glabrata fungemia with shock in a pregnant woman successfully treated with high doses of fluconazole and delivery of healthy child.
Topics: Adult; Candida; Cross Infection; Female; Fluconazole; Fungemia; Humans; Infant, Newborn; Pregnancy; | 1995 |
Candida albicans brain abscesses in a premature infant treated with amphotericin B, flucytosine and fluconazole.
Topics: Amphotericin B; Brain Abscess; Candidiasis; Drug Therapy, Combination; Female; Fluconazole; Flucytos | 1995 |
In vitro activity of amphotericin B, flucytosine and fluconazole against yeasts causing bloodstream infections.
Topics: Amphotericin B; Fluconazole; Flucytosine; Fungemia; Humans; Microbial Sensitivity Tests; Yeasts | 1995 |
Efficacy of itraconazole in treating AIDS-associated infections due to Candida krusei.
Topics: Adult; AIDS-Related Opportunistic Infections; Candida; Candidiasis; Candidiasis, Oral; Dermatomycose | 1995 |
[Fungemia caused by Candida krusei in a female patient with AIDS].
Topics: Acquired Immunodeficiency Syndrome; Adult; Amphotericin B; Candida; Candidiasis, Oral; Female; Fluco | 1994 |
Fungemia due to fluconazole-resistant Candida albicans in a patient with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Candida albicans; Candidiasis; Drug | 1994 |
Fluconazole-resistant Candida albicans in an immunocompetent child.
Topics: Candida albicans; Candidiasis; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Immunocomp | 1994 |
The treatment of candidemia.
Topics: Amphotericin B; Candidiasis; Catheterization; Fluconazole; Fungemia; Humans | 1995 |
The treatment of candidemia.
Topics: Amphotericin B; Candidiasis; Fluconazole; Fungemia; Humans | 1995 |
The treatment of candidemia.
Topics: Amphotericin B; Candidiasis; Catheterization, Central Venous; Fluconazole; Fungemia; Humans | 1995 |
The treatment of candidemia.
Topics: Amphotericin B; Candida; Candidiasis; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests | 1995 |
Management of candidemia.
Topics: Adult; Amphotericin B; Candidiasis; Fluconazole; Fungemia; Humans; Neutropenia | 1994 |
Fluconazole susceptibilities of Candida species and distribution of species recovered from blood cultures over a 5-year period.
Topics: Candida; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; Time Factors | 1994 |
Pyrolysis typing of isolates from a recurrence of systemic cryptococcosis.
Topics: Aged; Aneurysm; Asthma; Blood Vessel Prosthesis; Cryptococcosis; Cryptococcus neoformans; Diabetes M | 1994 |
Case report: Candida meningitis with an intradural filling defect 1 year after candidemia.
Topics: Amphotericin B; Candida albicans; Candidiasis; Catheters, Indwelling; Female; Fluconazole; Fungemia; | 1994 |
Medical treatment of recurrent candidemia in a patient with probable Candida parapsilosis prosthetic valve endocarditis.
Topics: Amphotericin B; Candidiasis; Drug Therapy, Combination; Endocarditis; Fluconazole; Fungemia; Heart V | 1994 |
Native valve endocarditis due to Candida parapsilosis: a late complication after bone marrow transplantation-related fungemia.
Topics: Adult; Amphotericin B; Bone Marrow Transplantation; Candida; Candidiasis; Endocarditis; Female; Fluc | 1994 |
Failure of therapy with fluconazole for candidal endophthalmitis.
Topics: Adult; Amphotericin B; Candidiasis; Cross Infection; Endophthalmitis; Female; Fluconazole; Fungemia; | 1993 |
Systemic and gastrointestinal candidiasis of infant mice as model for antifungal therapy.
Topics: Amphotericin B; Animals; Candidiasis; Disease Models, Animal; Fluconazole; Flucytosine; Fungemia; Ga | 1993 |
Trichosporon beigelii fungaemia in an AIDS patient.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Female; Fluconazol | 1993 |
Treatment of Candida albicans fungaemia with fluconazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Candidiasis; Drug Administration Schedule; Female; Fluco | 1993 |
Fluconazole for primary prophylaxis of AIDS-associated cryptococcosis: a case-control study.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Antigens, Fungal; Case-Control Stud | 1995 |
Breakthrough candidemia during antifungal treatment with fluconazole in patients with hematologic malignancies.
Topics: Candida; Candidiasis; Catheterization, Central Venous; Disease Susceptibility; Drug Resistance, Micr | 1996 |
Antifungal combination therapy with granulocyte colony-stimulating factor and fluconazole in experimental disseminated candidiasis.
Topics: Animals; Antifungal Agents; Candidiasis; Disease Models, Animal; Drug Interactions; Drug Therapy, Co | 1995 |
Fluconazole failure in two cases of disseminated candidosis.
Topics: Aged; Antifungal Agents; Candida albicans; Candidiasis; Electrophoresis, Gel, Pulsed-Field; Female; | 1995 |
Bilateral endogenous Fusarium endophthalmitis associated with acquired immunodeficiency syndrome.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Cytomegalovirus Retinitis; | 1996 |
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; Candidiasis; Drug Resistance, Microbial; Flucon | 1996 |
[Clinical efficacy of fluconazole against fungal infections in hematological diseases].
Topics: Adult; Antifungal Agents; Female; Fluconazole; Fungemia; Humans; Injections, Intravenous; Leukemia; | 1996 |
Fluconazole-resistant Candida parapsilosis fungemia in a patient with AIDS.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis; Drug Resistance, Micro | 1996 |
Fatal Candida tropicalis fungaemia in a leukaemic patient receiving fluconazole prophylaxis.
Topics: Antifungal Agents; Candidiasis; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Leukemia, | 1996 |
Resistance to fluconazole and amphotericin in Candida albicans from AIDS patients.
Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida albicans; Candidia | 1996 |
Isolation and characterization of fluconazole- and amphotericin B-resistant Candida albicans from blood of two patients with leukemia.
Topics: Adolescent; Adult; Amphotericin B; Animals; Antifungal Agents; Candida albicans; Candidiasis; Drug R | 1997 |
[Clinical aspects and prognosis of candidemia, a 6-year retrospective study].
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluco | 1996 |
Occurrence of yeast bloodstream infections between 1987 and 1995 in five Dutch university hospitals.
Topics: Antifungal Agents; Candidiasis; Censuses; Cross Infection; Cryptococcosis; Drug Resistance, Microbia | 1996 |
Hospital-acquired candidaemia: experience from a developing country.
Topics: Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Candidiasis; Child; Child, Preschool; Cr | 1997 |
Candida parapsilopsis fungemias in bone marrow transplant recipients: implications for azole prophylactic therapy.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Bone Marrow Transplantation; Candida; Candidiasis; Femal | 1997 |
Detection and identification of fungal pathogens in blood by using molecular probes.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; DNA, Fungal; Fl | 1997 |
The epidemiology of hematogenous candidiasis caused by different Candida species.
Topics: Adult; Aged; Candida; Candidiasis; Female; Fluconazole; Fungemia; Humans; Male; Middle Aged; Retrosp | 1997 |
[Phagocytosis of fungi in the peripheral blood neutrophils of two children with cancer during treatment with fluconazole].
Topics: Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Drug Resistance, Microbial; Female | 1997 |
Implications of early systemic therapy on the incidence of endogenous fungal endophthalmitis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Amphotericin B; Antifungal Agents; Child; Child, Pres | 1997 |
Candida famata fungemia in a surgical patient successfully treated with fluconazole.
Topics: Aged; Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Humans; Postoperative Complicat | 1997 |
Widespread cutaneous cryptococcosis occurring in an immunocompromised patient treated with high doses of fluconazole for oro-pharyngeal candidosis.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Cryptococcosis; | 1997 |
Resistance pattern of 2816 isolates isolated from 17631 blood cultures and etiology of bacteremia and fungemia in a single cancer institution.
Topics: Aminoglycosides; Anti-Bacterial Agents; Anti-Infective Agents; Antifungal Agents; Bacteremia; Cephal | 1997 |
The treatment of systemic candidiasis in neonates with oral fluconazole.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Follow-Up Studies; Fungemia; Hematologic Tests; Humans; | 1997 |
Unusual outcome of disseminated candidiasis treated with fluconazole: a matter of pharmacokinetics?
Topics: Adult; Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Humans | 1998 |
[Candidemia: a never ceasing challenge].
Topics: Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Fluconazole; Fungemia; Humans; Retr | 1997 |
[Current treatment of candidemia in non-neutropenic patients. Amphotericin B or fluconazole? A retrospective study of 62 consecutive patients].
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Blood; Candida; Candida albicans; Candidiasis; Cathe | 1997 |
Nosocomial breakthrough fungaemia during antifungal prophylaxis or empirical antifungal therapy in 41 cancer patients receiving antineoplastic chemotherapy: analysis of aetiology risk factors and outcome.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Cross Infection; Drug Resistance, Microbia | 1998 |
A case report of Candida parapsilosis endocarditis.
Topics: Antifungal Agents; Aortic Valve; Aortic Valve Stenosis; Candidiasis; Catheterization, Central Venous | 1998 |
Candidemia: a nosocomial complication in adults with late-stage AIDS.
Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Cand | 1998 |
National surveillance of nosocomial blood stream infection due to Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; Drug Resistance, Microbial; Fluco | 1998 |
Hospital specificity, region specificity, and fluconazole resistance of Candida albicans bloodstream isolates.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Cross Infection; DNA Fingerprinting; DNA, Fungal; | 1998 |
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participa
Topics: Antifungal Agents; Canada; Candida; Candidiasis; Fluconazole; Fungemia; Humans; International Cooper | 1998 |
Fluconazole and the changing epidemiology of candidemia.
Topics: Antifungal Agents; Candidiasis; Fluconazole; Fungemia; Humans | 1998 |
Pharmacokinetics of oral fluconazole in premature infants.
Topics: Administration, Oral; Antifungal Agents; Candidiasis; Dose-Response Relationship, Drug; Drug Adminis | 1998 |
Analysis by pulsed-field gel electrophoresis of Candida albicans that developed resistance during antifungal therapy.
Topics: Amphotericin B; Antifungal Agents; Candida albicans; DNA, Fungal; Drug Resistance, Microbial; Electr | 1998 |
Candida fungemia in neonates treated with fluconazole: report of forty cases, including eight with meningitis.
Topics: Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Humans; Infant; Infant, Newborn; Male | 1998 |
Candida parapsilosis fungemia in cancer patients--incidence, risk factors and outcome.
Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candidiasis; Child; Female; Flu | 1998 |
The use of fluconazole as a local irrigant for nephrostomy tubes.
Topics: Adult; Antifungal Agents; Candidiasis; Carcinoma, Squamous Cell; Fatal Outcome; Female; Fluconazole; | 1999 |
Trends in species distribution and susceptibility to fluconazole among blood stream isolates of Candida species in the United States.
Topics: Antifungal Agents; Candida; Candidiasis; Fluconazole; Fungemia; Humans; Microbial Sensitivity Tests; | 1999 |
In vitro susceptibilities of Candida and Cryptococcus neoformans isolates from blood cultures of neutropenic patients.
Topics: Candida; Cryptococcus neoformans; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans; Microbi | 1999 |
[Epidemiology of fungemia in a university hospital; therapeutic incidence].
Topics: Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Child, Pres | 1999 |
[A multicenter study on fungemia caused by yeasts in Spain (April-June, 1997). A Work Group to Study Fungemia)].
Topics: Adult; Age Factors; Aged; Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross-Sectional S | 1999 |
Persistent candidemia in a premature infant treated with fluconazole.
Topics: Antifungal Agents; Candida albicans; Candidiasis; Fluconazole; Fungemia; Humans; Infant, Newborn; In | 1999 |
Cytokines in sepsis due to Candida albicans and in bacterial sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Bacteremia; Candidias | 1999 |
Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution.
Topics: Adrenal Cortex Hormones; Amphotericin B; Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal A | 1999 |
Community-acquired fungemia due to a multiple-azole-resistant strain of Candida tropicalis.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Clotrimazole; Community-Acquired Infections | 1999 |
Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Bone Marrow Transplantation; Candidiasis; Child; Child, P | 2000 |
Immunization with the Candida albicans membrane fraction and in combination with fluconazole protects against systemic fungal infections.
Topics: Animals; Antibodies, Monoclonal; Antifungal Agents; Antigens, Fungal; Candida albicans; Candidiasis; | 2000 |
[Candida albicans fungemia with pulmonary localization treated with fluconazole. A case report].
Topics: Adult; Anti-Bacterial Agents; Antifungal Agents; Candidiasis; Catheterization, Central Venous; Cross | 2000 |
Delay of onset of candidemia and emergence of Candida krusei fungemia in hematologic patients receiving prophylactic fluconazole.
Topics: Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Hematologic Neoplasms; Humans; Male; | 2000 |
HIV/AIDS case histories: diagnostic problems. Cryptococcoma of the lung.
Topics: Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Autopsy; Fatal Outcome; Fluconazole | 1999 |
Candida krusei fungemia. An escalating serious infection in immunocompromised patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Antineoplastic Agents | 2000 |
Fluconazole therapy in neonatal candidemia.
Topics: Antifungal Agents; Candidiasis; Drug Administration Schedule; Female; Fluconazole; Fungemia; Humans; | 2000 |
Candida lusitaniae: a cause of breakthrough fungemia in cancer patients.
Topics: Adult; Aged; Amphotericin B; Antifungal Agents; Bone Marrow Transplantation; Candida; Candidiasis; D | 2001 |
Clinical applicability of antifungal susceptibility testing on non-Candida albicans species in hospitalized patients.
Topics: Amphotericin B; Antifungal Agents; Azoles; Candida; Candidiasis; Drug Resistance, Microbial; Flucona | 2001 |
Candidemia before and during the fluconazole era: prevalence, type of species and approach to treatment in a tertiary care community hospital.
Topics: Adolescent; Adult; Aged; Antifungal Agents; Candida; Candidiasis; Child; Child, Preschool; Drug Util | 2001 |
Pharmacokinetics of sequential intravenous and enteral fluconazole in critically ill surgical patients with invasive mycoses and compromised gastro-intestinal function.
Topics: Antifungal Agents; Area Under Curve; Biological Availability; Digestive System Surgical Procedures; | 2001 |
Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a university hospital.
Topics: Antifungal Agents; Candida; Colony Count, Microbial; Cross Infection; Drug Resistance, Microbial; Fl | 2001 |
Fungaemia in elderly patients.
Topics: Aged; Aged, 80 and over; Amphotericin B; Antifungal Agents; Candidiasis; Cross Infection; Female; Fl | 2001 |
Antifungal susceptibility testing of fluconazole by flow cytometry correlates with clinical outcome.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Blood; Candida; Candidiasis; Culture | 2001 |
Standardization of antifungal susceptibility variables for a semiautomated methodology.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Colony Count, Microbial; Dimethyl Sulfoxide | 2001 |
Candida sepsis following transcervical chorionic villi sampling.
Topics: Adult; Antifungal Agents; Candida albicans; Candidiasis; Chorionic Villi Sampling; Diagnosis, Differ | 2001 |
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surv
Topics: Antifungal Agents; Candida; Candidiasis; Europe; Fluconazole; Fungemia; Humans; Latin America; North | 2001 |
Use of fluconazole in newborn infants with systemic candidiasis.
Topics: Antifungal Agents; Candidiasis; Female; Fluconazole; Fungemia; Humans; Infant, Newborn; Male; Retros | 2001 |
Fluconazole and Candida krusei fungemia.
Topics: Candidiasis; Drug Resistance, Fungal; Fluconazole; Fungemia; Humans; Italy; Opportunistic Infections | 2001 |
Breakthrough fungaemia in neonates and infants caused by Candida albicans and Candida parapsilosis susceptible to fluconazole in vitro.
Topics: Antifungal Agents; Candida; Candida albicans; Candidiasis; Female; Fluconazole; Fungemia; Humans; In | 2001 |
Scedosporium endophthalmitis: two fatal disseminated cases of Scedosporium infection presenting with endophthalmitis.
Topics: Acute Disease; Adult; Amphotericin B; Antifungal Agents; Endophthalmitis; Eye Infections, Fungal; Fa | 2001 |
Breakthrough candidaemias during empirical therapy with fluconazole in non-cancer and non-HIV adults caused by in vitro-susceptible Candida spp.: report of 33 cases.
Topics: Adult; Analysis of Variance; Antifungal Agents; Candida; Candidiasis; Fluconazole; Fungemia; Humans; | 2001 |
Case report. Cutaneous cryptococcosis in a patient with systemic erythematous lupus.
Topics: Adult; Agglutination Tests; Amphotericin B; Antifungal Agents; Antigens, Fungal; Cellulitis; Cryptoc | 2001 |
Candida glabrata and Candida krusei fungemia after high-risk allogeneic marrow transplantation: no adverse effect of low-dose fluconazole prophylaxis on incidence and outcome.
Topics: Adolescent; Adult; Antifungal Agents; Bacteremia; Bone Marrow Transplantation; Candida; Candidiasis; | 2001 |
Candida dubliniensis candidaemia in an HIV-positive patient in Ireland.
Topics: Adult; Antifungal Agents; Candida; Candidiasis; DNA, Fungal; Fatal Outcome; Fluconazole; Fungemia; H | 2002 |
Antifungal susceptibility of 262 bloodstream yeast isolates from a mixed cancer and non-cancer patient population: is there a correlation between in-vitro resistance to fluconazole and the outcome of fungemia?
Topics: Adult; Antifungal Agents; Candida; Candida albicans; Child; Drug Resistance, Fungal; Fluconazole; Fu | 2000 |
Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use.
Topics: Antifungal Agents; Candida; Candidiasis; Cross Infection; Fluconazole; Fungemia; Humans; Incidence; | 2002 |
The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer.
Topics: Amphotericin B; Antifungal Agents; APACHE; Bone Marrow Transplantation; Candida albicans; Candidiasi | 2002 |
[Candidemia in elderly people: apropos of 4 cases].
Topics: Aged; Aged, 80 and over; Antifungal Agents; Candida; Candidiasis; Female; Fluconazole; Frail Elderly | 2002 |
Risk factors for breakthrough candidemia.
Topics: Amphotericin B; Anti-Bacterial Agents; Candidiasis; Fluconazole; Fungemia; Humans; Multivariate Anal | 2002 |
Nosocomial candidemia in a tertiary care hospital in Saudi Arabia.
Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis; Cross Infection; Female; Fluconazole; Funge | 2002 |
Case Report. Acremonium falciforme fungemia in a patient with acute leukaemia.
Topics: Acremonium; Adolescent; Antifungal Agents; Fatal Outcome; Fluconazole; Fungemia; Humans; Male; Mycos | 2002 |
Fungemia caused by Hansenula anomala: successful treatment with fluconazole.
Topics: Carcinoma, Small Cell; Female; Fluconazole; Fungemia; Humans; Lung Neoplasms; Middle Aged; Opportuni | 1992 |
Failure of fluconazole in systemic candidiasis.
Topics: Adult; Amphotericin B; Candidiasis; Female; Fluconazole; Fungemia; Humans | 1992 |
Persistence of the same Candida albicans strain despite fluconazole therapy. Documentation by pulsed-field gel electrophoresis.
Topics: Candida; Candida albicans; Candidiasis; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; Fluconazole | 1992 |
[Candida infections in premature infants weighing less than 1,500 g. Mucocutaneous colonization and incidence of systemic infections].
Topics: Candidiasis, Chronic Mucocutaneous; Cesarean Section; Cross Infection; Cross-Sectional Studies; Drug | 1992 |
Disseminated fungal disease resistant to fluconazole treatment in a child with leukemia.
Topics: Child, Preschool; Drug Resistance, Microbial; Female; Fluconazole; Fungemia; Humans; Precursor Cell | 1992 |
Treatment of candidemia in critically ill surgical patients with intravenous fluconazole.
Topics: Adolescent; Aged; Candidiasis; Cross Infection; Female; Fluconazole; Fungemia; Humans; Injections, I | 1992 |
Successful treatment of recurrent hepatic Candida infection with fluconazole after chemotherapy for acute leukemia: a case report.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Candidiasis; Fluconazole; Fungemia; H | 1992 |
Fluconazole therapy in a child with Candida tropicalis fungemia.
Topics: Amphotericin B; Candidiasis; Child, Preschool; Fluconazole; Fungemia; Humans; Male; Risk Factors | 1992 |
Fluconazole and Candida krusei infections.
Topics: Acute Disease; Candidiasis; Drug Resistance, Microbial; Female; Fluconazole; Fungemia; Humans; Leuke | 1991 |
Fluconazole and Candida krusei fungemia.
Topics: Candida; Candidiasis; Drug Resistance, Microbial; Fluconazole; Fungemia; Humans | 1991 |